2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of arrhythmia Jg. 33; H. 4; S. 345 - 367
Hauptverfasser: Chiang, Chern‐En, Okumura, Ken, Zhang, Shu, Chao, Tze‐Fan, Siu, Chung‐Wah, Wei Lim, Toon, Saxena, Anil, Takahashi, Yoshihide, Siong Teo, Wee
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Japan John Wiley & Sons, Inc 01.08.2017
Elsevier
Wiley
Schlagworte:
Age
Anticoagulants
Anticoagulation
Asian people
Atrial fibrillation
Cardiac arrhythmia
Cardiology
Diabetes
Disease prevention
Females
Guideline
Heart failure
Hypertension
Ischemia
Non-vitamin K antagonist oral anticoagulants
Patients
Risk factors
Stroke
Transient ischemic attack
Vitamin K antagonist
Asia
East Asia
Taiwan
Stroke
Anticoagulation
Vitamin K antagonist
Atrial fibrillation
Non-vitamin K antagonist oral anticoagulants
ISSN:1880-4276, 1883-2148
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF‐associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non‐vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub‐committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub‐committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.
AbstractList Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.
Author Siu, Chung‐Wah
Saxena, Anil
Takahashi, Yoshihide
Chiang, Chern‐En
Wei Lim, Toon
Chao, Tze‐Fan
Siong Teo, Wee
Zhang, Shu
Okumura, Ken
AuthorAffiliation j National Heart Centre, Singapore
d Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
b Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan
c State Key Laboratory of Cardiovascular Disease, Fuwai Hospital; National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People׳s Republic of China
e Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan
h Cardiac Pacing & Electrophysiology Center, Fortis Escorts Heart Institute, New Delhi, India
g National University Heart Centre, National University Hospital, Singapore
f Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China
i Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan
a General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital
AuthorAffiliation_xml – name: c State Key Laboratory of Cardiovascular Disease, Fuwai Hospital; National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People׳s Republic of China
– name: a General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan
– name: b Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan
– name: j National Heart Centre, Singapore
– name: d Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
– name: g National University Heart Centre, National University Hospital, Singapore
– name: i Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan
– name: h Cardiac Pacing & Electrophysiology Center, Fortis Escorts Heart Institute, New Delhi, India
– name: e Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan
– name: f Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China
Author_xml – sequence: 1
  givenname: Chern‐En
  surname: Chiang
  fullname: Chiang, Chern‐En
  email: cechiang@vghtpe.gov.tw
– sequence: 2
  givenname: Ken
  surname: Okumura
  fullname: Okumura, Ken
– sequence: 3
  givenname: Shu
  surname: Zhang
  fullname: Zhang, Shu
– sequence: 4
  givenname: Tze‐Fan
  surname: Chao
  fullname: Chao, Tze‐Fan
– sequence: 5
  givenname: Chung‐Wah
  surname: Siu
  fullname: Siu, Chung‐Wah
– sequence: 6
  givenname: Toon
  surname: Wei Lim
  fullname: Wei Lim, Toon
– sequence: 7
  givenname: Anil
  surname: Saxena
  fullname: Saxena, Anil
– sequence: 8
  givenname: Yoshihide
  surname: Takahashi
  fullname: Takahashi, Yoshihide
– sequence: 9
  givenname: Wee
  surname: Siong Teo
  fullname: Siong Teo, Wee
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28765771$$D View this record in MEDLINE/PubMed
BookMark eNqFUstuEzEUHaEi-oAPYIMssWGT4OvX2BukqAJaVKmIx9q643gaD5NxsCdF-Xs8SaloF7CydXzO8bmP0-poiIOvqpdA50BBve3mXcQ5o1DPqZxTKp5UJ6A1nzEQ-mh_pzPBanVcnebcUSq1AHhWHTNdK1nXcFK5SU1cHLIf8jaT2JJx5ckiBySf0YU2OHLhMY3ky2o3rtbka3TBjzsSB5LHFH94skn-1g9jKEgYCI4pYE_a0KTQ9zjBz6unLfbZv7g7z6rvH95_O7-YXV1_vDxfXM2c4lTOlFaiEZz5eikMMtEqFJw3jXHtstFIweiCeWM0QyXRcVwyQIGCSmmc0_ysujz4LiN2dpPCGtPORgx2D8R0Y0shwfXeigYcCOYcGCV4yxuulW6MBu7rFh0Ur3cHr822WfulKwUm7B-YPnwZwsrexFsrJTPSTGHe3Bmk-HPr82jXITtfWjL4uM0WDJMSqIaJ-voRtYvbNJRWWU5rUSvGtSisV38nuo_yZ5aFAAeCSzHn5Nt7ClA77YvtijHaaeKWSlv2pWjqRxoXxv3QSlGh_6dSHZS_Qu93___KfrpecC4k_w3E_9YN
CitedBy_id crossref_primary_10_1161_STROKEAHA_119_026054
crossref_primary_10_1186_s43044_021_00194_1
crossref_primary_10_1002_joa3_12186
crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_105034
crossref_primary_10_1093_eurheartj_suaa180
crossref_primary_10_1161_STROKEAHA_118_021047
crossref_primary_10_1093_eurheartj_suaa176
crossref_primary_10_1002_joa3_12225
crossref_primary_10_1093_eurheartj_suaa178
crossref_primary_10_1016_j_hrthm_2025_08_007
crossref_primary_10_1161_JAHA_121_023907
crossref_primary_10_1161_STROKEAHA_117_018551
crossref_primary_10_1186_s12872_022_02842_z
crossref_primary_10_7759_cureus_25102
crossref_primary_10_1097_JCMA_0000000000000516
crossref_primary_10_1371_journal_pone_0242922
crossref_primary_10_1186_s12872_023_03643_8
crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106905
crossref_primary_10_3390_jcm8060882
crossref_primary_10_1016_j_ijcard_2017_12_027
crossref_primary_10_1177_1074248419868996
crossref_primary_10_7717_peerj_16545
crossref_primary_10_1111_jocn_15993
crossref_primary_10_1007_s10741_019_09878_y
crossref_primary_10_1016_j_hlc_2018_02_024
crossref_primary_10_1080_14656566_2018_1515913
crossref_primary_10_1097_MD_0000000000026272
crossref_primary_10_1186_s12872_023_03179_x
crossref_primary_10_1186_s12872_018_0911_4
crossref_primary_10_1186_s12875_021_01453_5
crossref_primary_10_3390_jcm11071823
crossref_primary_10_3389_fmed_2020_00054
crossref_primary_10_1109_ACCESS_2024_3467181
crossref_primary_10_1136_postgradmedj_2019_136404
crossref_primary_10_3390_bioengineering11090903
crossref_primary_10_1055_s_0041_1739411
crossref_primary_10_1111_ijcp_13352
crossref_primary_10_2147_CLEP_S358277
crossref_primary_10_1007_s40801_022_00311_9
crossref_primary_10_35755_jmedassocthai_2020_06_10827
crossref_primary_10_3389_fphar_2023_1286559
crossref_primary_10_1007_s40256_023_00570_z
crossref_primary_10_1097_JCMA_0000000000000050
crossref_primary_10_1111_jcmm_17405
crossref_primary_10_1177_17474930211046743
crossref_primary_10_1038_s41569_020_00459_3
crossref_primary_10_1093_europace_euab065
crossref_primary_10_3390_jcdd9020046
crossref_primary_10_1016_j_amjcard_2018_11_046
crossref_primary_10_1186_s12875_025_02905_y
crossref_primary_10_1161_JAHA_120_016271
crossref_primary_10_1002_joa3_12878
crossref_primary_10_1007_s10840_022_01128_w
crossref_primary_10_1007_s40119_025_00400_0
crossref_primary_10_2217_cer_2019_0197
crossref_primary_10_1093_eurjcn_zvae177
crossref_primary_10_3389_fneur_2022_761603
crossref_primary_10_1016_j_tcm_2018_11_012
crossref_primary_10_1016_j_thromres_2021_10_015
crossref_primary_10_1093_eurheartj_ehy837
crossref_primary_10_3389_fneur_2020_00184
crossref_primary_10_1007_s40256_023_00623_3
crossref_primary_10_18087_cardio_2021_12_n1872
crossref_primary_10_1002_joa3_12669
crossref_primary_10_1080_00015385_2022_2030555
crossref_primary_10_1016_j_amjmed_2017_09_009
crossref_primary_10_1016_j_tcm_2021_12_001
crossref_primary_10_1055_a_1336_0476
crossref_primary_10_1136_openhrt_2020_001343
crossref_primary_10_3390_jcm9061698
crossref_primary_10_1007_s12170_019_0599_8
crossref_primary_10_1007_s11739_019_02169_2
crossref_primary_10_1016_j_jfma_2023_10_007
crossref_primary_10_1007_s40119_022_00254_w
crossref_primary_10_3389_fneur_2025_1576250
crossref_primary_10_1097_MD_0000000000021025
crossref_primary_10_1002_joa3_12652
crossref_primary_10_1186_s12944_022_01682_2
crossref_primary_10_1002_jac5_1285
crossref_primary_10_1186_s40001_022_00738_4
crossref_primary_10_1055_s_0042_1750385
crossref_primary_10_1080_03007995_2020_1796611
crossref_primary_10_1002_cpt_1601
crossref_primary_10_3390_jcm10173918
crossref_primary_10_1111_ijcp_13280
crossref_primary_10_1177_23969873241296803
crossref_primary_10_3389_fcvm_2021_682538
crossref_primary_10_3390_biomedicines12102242
crossref_primary_10_1038_s41598_019_50856_z
crossref_primary_10_1186_s13063_022_06250_8
crossref_primary_10_3389_fphar_2024_1399955
crossref_primary_10_1186_s42444_021_00038_8
crossref_primary_10_1016_j_ijcard_2018_07_044
crossref_primary_10_1111_pace_14381
crossref_primary_10_1016_j_ijcard_2017_11_025
crossref_primary_10_1002_joa3_12321
crossref_primary_10_1007_s00392_022_01996_2
crossref_primary_10_1136_openhrt_2021_001745
crossref_primary_10_1177_10600280231166643
crossref_primary_10_1016_j_heliyon_2023_e19079
crossref_primary_10_1186_s12944_020_01392_7
crossref_primary_10_3390_jcm10225337
crossref_primary_10_1007_s10741_019_09887_x
crossref_primary_10_1093_ehjcvp_pvad058
crossref_primary_10_3389_fphar_2021_615953
crossref_primary_10_1016_j_ejim_2022_04_023
crossref_primary_10_1093_ehjqcco_qcab050
crossref_primary_10_3389_fcvm_2025_1464567
crossref_primary_10_1016_j_lanwpc_2025_101570
crossref_primary_10_1007_s11096_019_00901_8
crossref_primary_10_1016_j_tcm_2018_11_003
crossref_primary_10_2217_fca_2022_0050
crossref_primary_10_1093_ehjqcco_qcab054
crossref_primary_10_1186_s12872_020_01544_8
crossref_primary_10_1161_STROKEAHA_120_029295
crossref_primary_10_2196_28266
crossref_primary_10_1093_eurheartj_suaa104
Cites_doi 10.1016/j.jacc.2008.03.067
10.1161/CIRCEP.113.000320
10.1161/CIRCULATIONAHA.113.004777
10.1182/blood-2012-11-468207
10.1007/s00392-014-0797-9
10.1253/circj.CJ-14-1245
10.1161/CIRCULATIONAHA.115.019794
10.1016/j.jacc.2016.12.038
10.1038/srep24376
10.1016/j.hrthm.2012.12.011
10.1161/CIRCEP.111.964916
10.1016/j.hrthm.2014.04.021
10.1016/S0735-1097(02)02052-1
10.1016/j.jtcvs.2008.06.002
10.1161/CIRCULATIONAHA.114.014343
10.1161/01.STR.21.2.230
10.1378/chest.13-0054
10.1016/0049-3848(95)00162-K
10.1253/circj.CJ-14-1131
10.1016/j.jacc.2013.03.035
10.1016/j.jacc.2016.02.082
10.1016/j.jacc.2016.06.057
10.1161/CIRCULATIONAHA.111.020982
10.1159/000186153
10.1016/j.jacc.2009.07.037
10.1161/STROKEAHA.116.013378
10.1016/j.jstrokecerebrovasdis.2016.04.006
10.1111/j.1540-8167.2009.01540.x
10.1161/CIRCULATIONAHA.111.090464
10.1007/s40264-016-0443-8
10.1016/j.jacc.2011.12.014
10.1016/j.jfma.2016.10.005
10.1161/STROKEAHA.113.004506
10.1093/europace/euv309
10.1016/0003-4975(95)00887-X
10.1177/0091270005274550
10.1161/CIRCULATIONAHA.110.964171
10.1159/000180580
10.1111/j.1538-7836.2012.04630.x
10.1136/bmj.d124
10.1161/CIRCULATIONAHA.116.022361
10.1056/NEJMoa1611594
10.1093/eurheartj/ehu421
10.1056/NEJMoa1007432
10.1186/1471-2369-4-1
10.4244/EIJV6I2A35
10.1161/CIRCULATIONAHA.112.107128
10.1093/eurheartj/ehu139
10.1053/j.ajkd.2015.05.019
10.1161/STROKEAHA.116.013880
10.1016/j.jacc.2012.02.008
10.1016/j.jacc.2007.01.098
10.1016/j.jstrokecerebrovasdis.2015.07.016
10.1182/blood-2014-08-595496
10.1016/S0140-6736(10)61194-4
10.1016/j.ahj.2005.04.017
10.20452/pamw.3049
10.1016/j.jacc.2013.02.025
10.1111/bcp.12055
10.1161/CIRCULATIONAHA.113.005754
10.1093/eurheartj/ehr488
10.5301/jn.5000010
10.1161/CIRCULATIONAHA.113.003628
10.1016/j.thromres.2011.11.005
10.1093/europace/euv190
10.1510/icvts.2009.227991
10.1016/S0140-6736(13)62376-4
10.1111/j.1540-8159.2009.02429.x
10.1681/ASN.2009030319
10.1160/TH14-03-0228
10.1160/TH13-11-0948
10.1161/JAHA.112.000067
10.1016/j.amjcard.2009.07.026
10.1111/j.1538-7836.2011.04572.x
10.1016/j.hrthm.2015.08.017
10.1016/S0140-6736(09)61343-X
10.1007/s00228-005-0043-5
10.1016/S0002-9343(01)00716-1
10.1016/S0140-6736(16)31257-0
10.1016/S0140-6736(16)00741-8
10.1161/CIRCULATIONAHA.112.114389
10.1159/000046216
10.1016/j.biopha.2016.06.012
10.1016/S0272-6386(12)80248-4
10.1161/CIRCULATIONAHA.116.026714
10.1161/CIR.0000000000000040
10.1038/ki.2009.477
10.1161/CIRCEP.113.000515
10.1253/circj.CJ-15-0574
10.1080/17425255.2016.1225037
10.1056/NEJMoa1510991
10.1111/j.1538-7836.2011.04498.x
10.1016/j.amjcard.2014.05.048
10.1016/S1474-4422(07)70274-0
10.1016/j.cjca.2014.04.015
10.1016/S0735-1097(02)01785-0
10.1161/CIRCOUTCOMES.110.958108
10.2215/CJN.03170509
10.1038/ki.2014.393
10.1038/nm.3102
10.1093/europace/euv289
10.1007/s00392-009-0091-4
10.1056/NEJMoa1009638
10.1016/j.amjmed.2005.06.029
10.1253/circj.CJ-14-0720
10.1001/jama.285.22.2864
10.1161/CIRCULATIONAHA.114.014807
10.1177/1060028014563950
10.1056/NEJMoa1105594
10.1161/STROKEAHA.113.000990
10.1016/j.jacc.2014.09.051
10.1056/NEJMoa0905561
10.1016/j.jacc.2012.09.057
10.1161/01.STR.22.8.983
10.1378/chest.15-1095
10.1378/chest.10-0134
10.1371/journal.pone.0150674
10.1016/j.ijcard.2014.11.182
10.1093/eurheartj/ehr342
10.1016/j.clinthera.2008.09.010
10.1001/jama.2014.15192
10.1111/bcp.12393
10.1160/TH14-11-0982
10.1111/jth.13305
10.1111/bcp.12075
10.1093/eurheartj/ehu181
10.1016/j.clinthera.2016.05.004
10.1016/j.cjca.2016.05.009
10.1067/mhj.2000.106648
10.1016/j.jacc.2014.11.046
10.1016/j.jacc.2014.06.008
10.1016/j.jacc.2015.03.601
10.1160/TH13-09-0734
10.1002/ccd.22764
10.1161/STROKEAHA.113.675140
10.4065/77.9.897
10.1016/j.acvd.2014.01.001
10.1253/circj.CJ-14-1042
10.1016/j.thromres.2014.02.024
10.1056/NEJMoa1310907
10.1093/eurheartj/ehs274
10.1016/j.hrthm.2011.12.016
10.1016/j.jcin.2014.06.014
10.1016/j.jacc.2012.06.019
10.1378/chest.11-2298
10.1161/STROKEAHA.113.002968
10.1182/blood-2012-06-415943
10.1136/bmj.h2391
10.1161/CIRCULATIONAHA.115.020950
10.1111/j.1365-2125.2012.04453.x
10.1093/europace/euw073
10.1136/heartjnl-2014-306332
10.1093/europace/eut083
10.1016/j.amjcard.2005.08.062
10.1161/01.STR.0000198839.61112.ee
10.1007/s00059-014-4188-9
10.1016/j.jacc.2014.06.1203
10.1016/j.jacc.2015.07.026
10.1016/j.hrthm.2014.03.003
10.1016/j.jacc.2016.12.031
10.1016/S1474-4422(10)70274-X
10.1056/NEJMoa1311376
10.1016/j.jacc.2013.04.089
10.1093/eurheartj/ehu298
10.1503/cmaj.150867
10.1161/STROKEAHA.112.650614
10.1016/j.hrthm.2016.03.049
10.1001/jama.2015.0846
10.1111/jth.13386
10.1016/j.cjca.2015.06.005
10.1002/ccd.24872
10.1016/j.jacc.2013.02.035
10.1161/CIRCULATIONAHA.115.018294
10.1253/circj.CJ-12-0454
10.1016/S1474-4422(12)70092-3
10.1111/bcp.12541
10.1056/NEJMoa1502000
10.1111/imj.12448
10.1016/j.ijcard.2015.09.035
10.1056/NEJMoa1501035
10.1161/CIRCEP.111.966713
10.1016/j.beha.2013.07.009
10.1161/CIRCULATIONAHA.115.015735
10.1016/j.amjmed.2015.10.001
10.1503/cmaj.150580
10.1159/000180784
10.1161/STROKEAHA.114.006476
10.1016/j.jtcvs.2011.07.052
10.1212/01.wnl.0000267275.68538.8d
10.7326/0003-4819-146-12-200706190-00007
10.2165/0003088-200948010-00001
10.1160/TH12-03-0175
10.1056/NEJMoa1300615
10.1016/j.ahj.2014.06.005
10.1001/archinte.1994.00420130036007
10.1124/jpet.111.180240
10.1056/NEJM200105103441901
10.1001/archinte.165.10.1095
10.1016/j.jacc.2014.04.029
10.1161/CIRCULATIONAHA.112.147512
10.1056/NEJMoa1701005
10.1161/CIRCULATIONAHA.113.005451
10.1016/j.ijcard.2008.10.045
10.1177/1076029609343004
10.1111/cns.12021
10.1016/j.jacc.2011.03.031
10.1093/europace/euw295
10.1161/JAHA.115.002322
10.1016/j.jacc.2015.05.044
10.1161/CIRCULATIONAHA.115.015688
10.1161/STROKEAHA.116.013540
10.1161/CIRCEP.113.000858
10.1093/ndt/gfm051
10.1378/chest.15-1719
10.1016/S0140-6736(13)62343-0
10.1161/CIRCEP.110.957100
10.1161/STROKEAHA.115.009947
10.1016/j.jacc.2012.06.046
10.1253/circj.CJ-15-1082
10.1111/bcp.12391
10.1161/CIRCULATIONAHA.108.844779
10.1016/S0140-6736(16)31474-X
10.1016/j.jstrokecerebrovasdis.2016.08.030
10.1056/NEJMoa1607887
10.1097/MJT.0000000000000121
10.2215/CJN.04550511
10.1001/jama.2014.1781
10.1093/eurheartj/eht557
10.1016/j.ahj.2004.09.054
10.1021/acs.biochem.5b00079
10.1093/eurheartj/ehu367
10.1016/j.jclinane.2016.06.016
10.1378/chest.09-1584
10.1016/j.cjca.2014.06.006
10.1161/STROKEAHA.108.516344
10.1016/j.ahj.2010.03.027
10.1046/j.1540-8167.2004.03401.x
10.1161/ATVBAHA.114.303402
10.1016/j.ijcard.2012.09.187
10.1016/S0002-9149(98)00704-8
10.1016/S1474-4422(12)70042-X
10.1161/CIRCULATIONAHA.110.977546
10.1001/jama.2014.1334
10.1097/FJC.0b013e3182970991
10.1093/eurheartj/eht328
10.1056/NEJMoa1107039
10.1111/j.1365-2125.2006.02776.x
10.7326/0003-4819-126-8-199704150-00005
10.1016/j.amjcard.2011.08.046
10.1093/eurheartj/ehu305
10.1159/000077341
10.1097/ALN.0b013e318289bcba
10.2215/CJN.02400311
10.1161/CIRCULATIONAHA.116.025923
10.1016/j.ijcard.2016.07.118
10.1016/j.hrthm.2016.09.010
10.1161/CIRCULATIONAHA.112.123992
10.1161/01.STR.0000087149.42294.8C
10.1007/s40261-015-0298-2
10.1161/JAHA.113.000250
10.1016/j.cjca.2013.06.015
10.1053/j.ajkd.2007.06.017
10.1016/j.jacc.2011.08.045
10.1093/ndt/13.8.2053
10.1038/ki.2011.223
10.1093/eurheartj/ehv177
10.1016/j.jacc.2013.09.062
ContentType Journal Article
Copyright 2017 Japanese Heart Rhythm Society
2017. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2017 Japanese Heart Rhythm Society. Published by Elsevier B.V. 2017 Japanese Heart Rhythm Society
Copyright_xml – notice: 2017 Japanese Heart Rhythm Society
– notice: 2017. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2017 Japanese Heart Rhythm Society. Published by Elsevier B.V. 2017 Japanese Heart Rhythm Society
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1016/j.joa.2017.05.004
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2148
EndPage 367
ExternalDocumentID oai_doaj_org_article_4b1c142cc19643f3b3868b9813e7fac1
PMC5529598
28765771
10_1016_j_joa_2017_05_004
JOA3345
Genre article
Journal Article
GeographicLocations Asia
East Asia
Taiwan
GeographicLocations_xml – name: East Asia
– name: Taiwan
– name: Asia
GrantInformation_xml – fundername: Ministry of Health and Welfare
  funderid: MOHW106‐TDU‐B‐211–113001
– fundername: Ministry of Science and Technology
  funderid: 105–2314‐B‐075‐037
– fundername: Taipei Veterans General Hospital
  funderid: V106C‐064
GroupedDBID 0R~
0SF
1OC
24P
2WC
4.4
457
4G.
53G
5GY
6I.
7-5
7X7
8FI
8FJ
AACTN
AAEDT
AAEDW
AAFTH
AAHHS
AAIKJ
AALRI
AAXUO
ABMAC
ABUWG
ACCFJ
ACCMX
ACGFS
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEKER
AEQDE
AEXQZ
AFKRA
AGHFR
AGYEJ
AITUG
AIWBW
AJBDE
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMRAJ
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BKOMP
BPHCQ
BVXVI
CCPQU
DIK
EBS
EIHBH
EJD
FDB
FIRID
FNPLU
FYUFA
GBLVA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
IPNFZ
ITC
IXB
JMI
JSF
JSH
KQ8
M41
MOJWN
NCXOZ
O-L
O9-
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
Q38
RIG
RJT
ROL
RPM
RZJ
SDF
SEL
SSZ
TEORI
TKC
UKHRP
WIN
AAMMB
AAYWO
AAYXX
ACVFH
ADCNI
AEFGJ
AEUPX
AFFHD
AFPUW
AGXDD
AIDQK
AIDYY
AIGII
AKBMS
AKYEP
CITATION
PHGZM
PHGZT
~HD
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c6305-6864b432e7d49a24f6a433bb9cfdb8a01984f6e9982a65ac3ad21a4a40559cc83
IEDL.DBID DOA
ISICitedReferencesCount 152
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000407853500019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1880-4276
IngestDate Tue Oct 14 18:44:46 EDT 2025
Tue Nov 04 01:43:04 EST 2025
Thu Oct 02 07:13:12 EDT 2025
Tue Oct 07 07:07:17 EDT 2025
Wed Feb 19 02:01:21 EST 2025
Tue Nov 18 22:33:33 EST 2025
Sat Nov 29 07:50:02 EST 2025
Wed Jan 22 16:21:23 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Stroke
Anticoagulation
Vitamin K antagonist
Atrial fibrillation
Non-vitamin K antagonist oral anticoagulants
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6305-6864b432e7d49a24f6a433bb9cfdb8a01984f6e9982a65ac3ad21a4a40559cc83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/4b1c142cc19643f3b3868b9813e7fac1
PMID 28765771
PQID 3074762384
PQPubID 4371420
PageCount 23
ParticipantIDs doaj_primary_oai_doaj_org_article_4b1c142cc19643f3b3868b9813e7fac1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5529598
proquest_miscellaneous_1925510818
proquest_journals_3074762384
pubmed_primary_28765771
crossref_primary_10_1016_j_joa_2017_05_004
crossref_citationtrail_10_1016_j_joa_2017_05_004
wiley_primary_10_1016_j_joa_2017_05_004_JOA3345
PublicationCentury 2000
PublicationDate August 2017
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: August 2017
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Journal of arrhythmia
PublicationTitleAlternate J Arrhythm
PublicationYear 2017
Publisher John Wiley & Sons, Inc
Elsevier
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Elsevier
– name: Wiley
References 2010; 99
1991; 17
2013; 127
2013; 369
2013; 62
2013; 61
2016; 32
2012; 19
2016; 2016
2012; 18
2008; 30
2013; 121
2005; 61
2016; 39
2016; 38
2012; 11
2012; 10
2016; 34
2013; 118
2015; 131
2015; 132
2015; 373
1996; 61
2012; 25
2010; 5
2016; 47
2011; 365
2011; 123
2011; 364
2010; 6
2010; 9
1998; 13
1994; 154
2006; 119
2001; 285
2017; 69
2015; 125
2002; 77
2008; 52
2016; 202
2011; 4
2016; 18
2017; 376
2011; 6
2017; 135
2012; 33
2016; 14
2014; 312
2016; 13
2016; 12
2016; 11
2011; 9
2014; 311
2001; 21
2016; 6
2013; 76
2015; 113
2013; 75
2015; 351
2013; 82
2008; 136
2012; 43
2016; 25
2016; 23
2011; 142
2013; 29
2001; 344
2007; 146
2015; 180
2013; 26
2016; 222
2014; 63
2014; 64
2013; 19
2013; 15
2014; 3
2013; 10
2002; 40
2010; 159
2003; 4
2014; 7
2007; 22
2014; 168
2010; 77
2002; 39
2005; 150
2015; 4
2011; 338
2013; 44
2017; 26
2016; 129
1995; 11
2010; 121
2006; 151
2007; 50
2001; 110
2007; 116
2005; 165
2010; 138
1991; 22
2010; 139
2013; 34
2010; 137
2010; 376
2016; 134
2016; 133
2016; 375
2000; 140
2014
2014; 78
2011; 342
2015; 79
2010; 10
2012; 120
1990; 56
2013; 2
2006; 37
2016; 388
2016; 387
2014; 370
2016; 149
2011; 58
1998; 82
2012; 367
2014; 133
2012; 126
2013; 6
2014; 129
2012; 130
2015; 87
2007; 6
2009; 361
2009; 120
2007; 63
2014; 11
2007; 69
2009; 15
2014; 124
2011; 80
2015; 54
2011; 77
2014; 2014
2014; 45
2012; 107
2014; 44
2012; 109
2003; 34
1990; 21
1977; 18
2015; 66
2015; 65
2014; 36
2014; 35
2014; 30
2014; 383
2009; 104
2015; 35
2012; 60
2015; 36
2009; 40
2012; 2012
2015; 104
2015; 31
2015; 101
2016; 188
2013; 168
2012; 59
2009; 48
2015; 46
2015; 49
2009; 54
2015; 40
2016; 83
2016; 80
2012; 141
2015; 17
2006; 97
2009; 20
2009; 374
2013; 144
2011; 32
2014; 111
2012; 76
2014; 114
2005; 45
2015; 24
2014; 107
1997; 126
1995; 80
2009; 32
2015; 313
2004; 17
2004; 15
1976; 16
2012; 5
2016; 68
2016; 67
2012; 9
e_1_2_13_143_2
e_1_2_13_189_2
e_1_2_13_20_2
e_1_2_13_43_2
e_1_2_13_66_2
O׳Brien E.C. (e_1_2_13_47_2) 2015; 36
e_1_2_13_166_2
e_1_2_13_203_2
e_1_2_13_8_2
e_1_2_13_181_2
e_1_2_13_226_2
e_1_2_13_81_2
e_1_2_13_249_2
e_1_2_13_275_2
e_1_2_13_92_2
e_1_2_13_117_2
Wazni O.M. (e_1_2_13_256_2) 2007; 116
e_1_2_13_17_2
e_1_2_13_131_2
e_1_2_13_154_2
e_1_2_13_177_2
e_1_2_13_78_2
e_1_2_13_55_2
e_1_2_13_215_2
e_1_2_13_32_2
e_1_2_13_192_2
e_1_2_13_238_2
e_1_2_13_70_2
e_1_2_13_264_2
e_1_2_13_241_2
e_1_2_13_105_2
e_1_2_13_128_2
e_1_2_13_88_2
e_1_2_13_29_2
e_1_2_13_142_2
e_1_2_13_165_2
e_1_2_13_188_2
e_1_2_13_67_2
e_1_2_13_44_2
e_1_2_13_21_2
e_1_2_13_180_2
e_1_2_13_225_2
e_1_2_13_248_2
e_1_2_13_82_2
e_1_2_13_9_2
e_1_2_13_251_2
e_1_2_13_274_2
e_1_2_13_91_2
e_1_2_13_116_2
e_1_2_13_213_2
e_1_2_13_99_2
e_1_2_13_153_2
e_1_2_13_199_2
e_1_2_13_56_2
e_1_2_13_79_2
e_1_2_13_130_2
e_1_2_13_10_2
e_1_2_13_176_2
e_1_2_13_214_2
e_1_2_13_191_2
e_1_2_13_237_2
e_1_2_13_71_2
Whitlock R. (e_1_2_13_139_2) 2014; 3
Tafur A. (e_1_2_13_211_2) 2015; 125
e_1_2_13_240_2
e_1_2_13_263_2
e_1_2_13_202_2
e_1_2_13_104_2
e_1_2_13_127_2
e_1_2_13_45_2
e_1_2_13_68_2
e_1_2_13_168_2
e_1_2_13_205_2
e_1_2_13_22_2
e_1_2_13_122_2
e_1_2_13_145_2
e_1_2_13_83_2
e_1_2_13_6_2
e_1_2_13_60_2
e_1_2_13_183_2
e_1_2_13_228_2
e_1_2_13_160_2
e_1_2_13_90_2
e_1_2_13_231_2
e_1_2_13_254_2
e_1_2_13_277_2
e_1_2_13_98_2
e_1_2_13_119_2
e_1_2_13_19_2
e_1_2_13_34_2
e_1_2_13_110_2
e_1_2_13_179_2
e_1_2_13_57_2
e_1_2_13_217_2
e_1_2_13_133_2
e_1_2_13_156_2
e_1_2_13_11_2
e_1_2_13_72_2
Di Biase L. (e_1_2_13_252_2) 2010; 121
e_1_2_13_171_2
e_1_2_13_194_2
e_1_2_13_220_2
e_1_2_13_266_2
e_1_2_13_243_2
e_1_2_13_107_2
Guo Y. (e_1_2_13_18_2) 2012; 19
e_1_2_13_23_2
e_1_2_13_69_2
e_1_2_13_121_2
e_1_2_13_46_2
Koretsune Y. (e_1_2_13_120_2) 2014
e_1_2_13_144_2
e_1_2_13_167_2
e_1_2_13_204_2
e_1_2_13_61_2
e_1_2_13_84_2
e_1_2_13_7_2
e_1_2_13_182_2
e_1_2_13_227_2
e_1_2_13_230_2
e_1_2_13_253_2
e_1_2_13_276_2
e_1_2_13_97_2
e_1_2_13_118_2
e_1_2_13_12_2
e_1_2_13_35_2
e_1_2_13_58_2
e_1_2_13_132_2
e_1_2_13_178_2
e_1_2_13_216_2
e_1_2_13_155_2
e_1_2_13_50_2
e_1_2_13_73_2
e_1_2_13_170_2
e_1_2_13_193_2
e_1_2_13_239_2
e_1_2_13_242_2
e_1_2_13_265_2
e_1_2_13_129_2
e_1_2_13_106_2
e_1_2_13_24_2
e_1_2_13_162_2
e_1_2_13_207_2
e_1_2_13_101_2
e_1_2_13_124_2
e_1_2_13_147_2
Bertoli S.V. (e_1_2_13_96_2) 1995; 11
e_1_2_13_185_2
e_1_2_13_85_2
e_1_2_13_62_2
e_1_2_13_233_2
e_1_2_13_159_2
e_1_2_13_210_2
e_1_2_13_271_2
e_1_2_13_13_2
e_1_2_13_59_2
e_1_2_13_219_2
e_1_2_13_36_2
e_1_2_13_112_2
e_1_2_13_135_2
e_1_2_13_158_2
e_1_2_13_173_2
e_1_2_13_196_2
e_1_2_13_74_2
e_1_2_13_51_2
e_1_2_13_150_2
e_1_2_13_4_2
e_1_2_13_222_2
e_1_2_13_268_2
e_1_2_13_245_2
e_1_2_13_109_2
e_1_2_13_260_2
e_1_2_13_48_2
e_1_2_13_25_2
e_1_2_13_146_2
e_1_2_13_169_2
e_1_2_13_184_2
e_1_2_13_206_2
e_1_2_13_100_2
e_1_2_13_86_2
e_1_2_13_63_2
e_1_2_13_123_2
e_1_2_13_40_2
e_1_2_13_5_2
Camm A.J. (e_1_2_13_33_2) 2012; 2012
e_1_2_13_161_2
e_1_2_13_229_2
e_1_2_13_232_2
e_1_2_13_255_2
e_1_2_13_95_2
e_1_2_13_270_2
e_1_2_13_14_2
e_1_2_13_37_2
e_1_2_13_218_2
e_1_2_13_111_2
e_1_2_13_157_2
e_1_2_13_195_2
e_1_2_13_52_2
e_1_2_13_75_2
e_1_2_13_134_2
e_1_2_13_172_2
e_1_2_13_221_2
e_1_2_13_244_2
e_1_2_13_267_2
e_1_2_13_108_2
e_1_2_13_49_2
e_1_2_13_164_2
e_1_2_13_209_2
e_1_2_13_26_2
e_1_2_13_141_2
e_1_2_13_87_2
e_1_2_13_41_2
e_1_2_13_64_2
e_1_2_13_103_2
e_1_2_13_187_2
e_1_2_13_247_2
e_1_2_13_250_2
e_1_2_13_273_2
e_1_2_13_94_2
e_1_2_13_235_2
e_1_2_13_115_2
e_1_2_13_212_2
e_1_2_13_138_2
e_1_2_13_38_2
e_1_2_13_152_2
e_1_2_13_15_2
e_1_2_13_30_2
e_1_2_13_76_2
e_1_2_13_114_2
e_1_2_13_175_2
e_1_2_13_198_2
e_1_2_13_53_2
e_1_2_13_236_2
e_1_2_13_259_2
e_1_2_13_190_2
e_1_2_13_262_2
e_1_2_13_2_2
e_1_2_13_224_2
e_1_2_13_201_2
e_1_2_13_126_2
e_1_2_13_149_2
e_1_2_13_27_2
e_1_2_13_140_2
e_1_2_13_163_2
e_1_2_13_208_2
e_1_2_13_65_2
e_1_2_13_125_2
e_1_2_13_186_2
e_1_2_13_42_2
e_1_2_13_102_2
e_1_2_13_269_2
e_1_2_13_80_2
e_1_2_13_272_2
e_1_2_13_93_2
e_1_2_13_234_2
e_1_2_13_257_2
e_1_2_13_137_2
e_1_2_13_16_2
e_1_2_13_39_2
e_1_2_13_151_2
e_1_2_13_31_2
e_1_2_13_54_2
e_1_2_13_77_2
e_1_2_13_136_2
e_1_2_13_174_2
e_1_2_13_113_2
e_1_2_13_197_2
e_1_2_13_258_2
e_1_2_13_261_2
e_1_2_13_3_2
e_1_2_13_223_2
e_1_2_13_246_2
e_1_2_13_200_2
e_1_2_13_148_2
e_1_2_13_28_2
e_1_2_13_89_2
25416564 - Clin Res Cardiol. 2015 May;104(5):418-29
26680239 - Circulation. 2016 Jan 19;133(3):265-72
23325525 - Circulation. 2013 Feb 12;127(6):720-9
27358434 - Circulation. 2016 Jul 5;134(1):24-36
26277496 - Heart Rhythm. 2016 Jan;13(1):46-53
24747420 - Heart Rhythm. 2014 Aug;11(8):1401-8
17395659 - Nephrol Dial Transplant. 2007 Jul;22(7):1910-5
24998121 - J Am Coll Cardiol. 2014 Jul 8;64(1):1-12
25148838 - Eur Heart J. 2014 Dec 14;35(47):3377-85
26304863 - Stroke. 2015 Sep;46(9):2555-61
25399274 - JAMA. 2014 Nov 19;312(19):1988-98
16385088 - Stroke. 2006 Feb;37(2):447-51
26988871 - J Thromb Haemost. 2016 May;14(5):875-85
21059484 - Lancet Neurol. 2010 Dec;9(12):1157-63
24552831 - Circulation. 2014 May 6;129(18):1850-9
22700854 - Circulation. 2012 Jul 17;126(3):343-8
17577005 - Ann Intern Med. 2007 Jun 19;146(12):857-67
8588193 - Thromb Res. 1995 Oct 15;80(2):161-8
21515813 - J Pharmacol Exp Ther. 2011 Jul;338(1):372-80
19696042 - Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S
24697979 - Br J Clin Pharmacol. 2014 Oct;78(4):877-85
23210726 - Br J Clin Pharmacol. 2013 Jul;76(1):107-13
25001152 - Am J Cardiol. 2014 Aug 15;114(4):646-53
22922413 - Eur Heart J. 2012 Nov;33(21):2719-47
25320240 - Blood. 2014 Dec 11;124(25):3692-8
27387994 - Stroke. 2016 Aug;47(8):2075-82
19071881 - Clin Pharmacokinet. 2009;48(1):1-22
9103128 - Ann Intern Med. 1997 Apr 15;126(8):615-20
11985904 - J Am Coll Cardiol. 2002 May 1;39(9):1436-42
27614026 - Heart Rhythm. 2016 Dec;13(12 ):2340-2347
23103146 - Int J Cardiol. 2013 Sep 20;168(1):515-22
20299623 - Chest. 2010 Nov;138(5):1093-100
2150218 - Nephron. 1990;56(3):271-6
25064581 - Can J Cardiol. 2014 Aug;30(8):888-97
23500298 - J Am Coll Cardiol. 2013 May 14;61(19):1998-2006
9874066 - Am J Cardiol. 1998 Dec 15;82(12):1545-7, A8
8018000 - Arch Intern Med. 1994 Jul 11;154(13):1449-57
27335063 - Europace. 2016 Sep;18(9):1308-18
23412815 - Catheter Cardiovasc Interv. 2013 Aug 1;82(2):283-9
26068927 - Clin Drug Investig. 2015 Jul;35(7):447-53
24963566 - N Engl J Med. 2014 Jun 26;370(26):2467-77
26088576 - Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1736-45
28302287 - J Am Coll Cardiol. 2017 Mar 21;69(11):1363-1371
24315724 - Lancet. 2014 Mar 15;383(9921):955-62
19901203 - Circulation. 2009 Nov 10;120(19):1927-32; discussion 1932
26378611 - Chest. 2016 Apr;149(4):951-9
20824765 - Catheter Cardiovasc Interv. 2011 Apr 1;77(5):700-6
26341732 - J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2613-8
21870978 - N Engl J Med. 2011 Sep 15;365(11):981-92
26424865 - Eur Heart J. 2015 Dec 7;36(46):3258-64
23416382 - Anesthesiology. 2013 Jun;118(6):1466-74
24722803 - Eur Heart J. 2015 Feb 1;36(5):297-306
26205604 - J Am Coll Cardiol. 2015 Jul 28;66(4):488-90
27687455 - J Clin Anesth. 2016 Nov;34:586-99
26888149 - Circ J. 2016;80(4):860-9
28302288 - J Am Coll Cardiol. 2017 Mar 21;69(11):1372-1382
22934291 - J Thromb Haemost. 2012 Apr;10 (4):692-4
27523274 - Can J Cardiol. 2016 Dec;32(12 ):1381-1387
25975659 - Eur Heart J. 2015 Jul 21;36(28):1805-11
25710659 - JAMA. 2015 Feb 24;313(8):824-36
24682348 - Circulation. 2014 Dec 2;130(23):2071-104
23583249 - J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6
27067661 - Sci Rep. 2016 Apr 12;6:24376
11403753 - Am J Med. 2001 Jun 15;110(9):694-702
19046608 - Int J Cardiol. 2010 Mar 4;139(2):173-80
17998456 - Circulation. 2007 Nov 27;116(22):2531-4
24326736 - Thromb Haemost. 2014 May 5;111(5):933-42
16443416 - Am J Med. 2006 Feb;119(2):142-6
25463377 - Int J Cardiol. 2015 Feb 1;180:246-54
21076159 - Circ Arrhythm Electrophysiol. 2011 Feb;4(1):26-32
23991661 - N Engl J Med. 2013 Sep 26;369(13):1206-14
18954645 - J Thorac Cardiovasc Surg. 2008 Oct;136(4):1019-27
27472258 - Int J Cardiol. 2016 Nov 1;222:47-50
21873708 - Eur Heart J. 2011 Oct;32(19):2387-94
23237911 - Heart Rhythm. 2013 Apr;10(4):483-9
25104528 - J Am Coll Cardiol. 2014 Aug 12;64(6):585-7
24500243 - Thromb Haemost. 2014 May 5;111(5):789-97
26106009 - Circulation. 2015 Aug 25;132(8):624-32
17679673 - Neurology. 2007 Aug 7;69(6):546-54
26696619 - CMAJ. 2016 Mar 15;188(5):361-2
18772063 - J Am Coll Cardiol. 2008 Sep 9;52(11):924-9
27590218 - Lancet. 2016 Oct 22;388(10055):1995-2003
26559317 - N Engl J Med. 2015 Dec 17;373(25):2413-24
24642004 - Thromb Res. 2014 May;133(5):782-9
1824735 - Am J Kidney Dis. 1991 Jan;17(1):38-42
24251359 - N Engl J Med. 2013 Nov 28;369(22):2093-104
19713308 - J Am Soc Nephrol. 2009 Oct;20(10):2223-33
17659197 - J Am Coll Cardiol. 2007 Jul 24;50(4):309-15
25966905 - Circulation. 2015 Jul 21;132(3):167-73
27435452 - Drug Saf. 2016 Sep;39(9):841-5
25500231 - J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82
11401607 - JAMA. 2001 Jun 13;285(22):2864-70
24658395 - Thromb Haemost. 2014 May 5;111(5):781-2
22664783 - Circ J. 2012;76(9):2104-11
16504638 - Am Heart J. 2006 Mar;151(3):713-9
24315725 - Lancet. 2014 Mar 15;383(9921):931-3
21757117 - J Am Coll Cardiol. 2011 Jul 19;58(4):395-401
20007681 - Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81
22933567 - Eur Heart J. 2012 Nov;33(22):2821-30
23391196 - J Am Coll Cardiol. 2013 Feb 12;61(6):651-8
19932791 - Am J Cardiol. 2009 Dec 1;104(11):1551-5
22497820 - J Am Coll Cardiol. 2012 Apr 17;59(16):1413-25
25587708 - Kidney Int. 2015 Jun;87(6):1209-15
25616425 - Herz. 2015 Apr;40 Suppl 2:140-5
24946813 - Intern Med J. 2014 Jun;44(6):525-36
24394381 - Eur Heart J. 2014 Jul 21;35(28):1888-96
23782923 - J Am Heart Assoc. 2013 Jun 21;2(3):e000250
27056738 - Lancet. 2016 Jun 4;387(10035):2302-11
17993293 - Lancet Neurol. 2007 Dec;6(12):1063-72
25573984 - Heart. 2015 Jun;101(11):877-83
24697922 - Br J Clin Pharmacol. 2014 Oct;78(4):908-17
15030415 - J Cardiovasc Electrophysiol. 2004 Mar;15(3):276-83
22246443 - Eur Heart J. 2012 Jun;33(12):1500-10
24743444 - Stroke. 2014 May;45(5):1304-12
16328318 - Eur J Clin Pharmacol. 2005 Dec;61(12):873-80
22315266 - Chest. 2012 Feb;141(2 Suppl):e326S-e350S
27507860 - Stroke. 2016 Sep;47(9):2197-202
15911722 - Arch Intern Med. 2005 May 23;165(10):1095-106
12233921 - Mayo Clin Proc. 2002 Sep;77(9):897-904
24463370 - Circulation. 2014 Apr 15;129(15):1568-76
23610543 - Malays J Med Sci. 2012 Jul;19(3):1-7
20801496 - Lancet. 2010 Sep 18;376(9745):975-83
23953899 - Best Pract Res Clin Haematol. 2013 Jun;26(2):103-14
19659617 - Pacing Clin Electrophysiol. 2009 Aug;32(8):995-9
26447666 - Int J Cardiol. 2016 Jan 1;202:578-85
22123000 - J Thromb Haemost. 2012 Feb;10(2):261-7
23319810 - Circulation. 2013 Jan 15;127(2):169-71
12225717 - J Am Coll Cardiol. 2002 Sep 4;40(5):926-33
26174061 - BMJ. 2015 Jul 14;351:h2391
21959598 - Clin J Am Soc Nephrol. 2011 Nov;6(11):2662-8
21906756 - J Thorac Cardiovasc Surg. 2011 Nov;142(5):1002-9, 1009.e1
24323795 - Circulation. 2014 Mar 4;129(9):961-70
26304938 - J Am Heart Assoc. 2015 Aug 24;4(8):e002322
19683639 - Lancet. 2009 Aug 15;374(9689):534-42
26324838 - Europace. 2015 Oct;17(10):1467-507
26504109 - Europace. 2016 May;18(5):665-71
26181726 - Chest. 2016 Feb;149(2):401-12
27311528 - J Am Coll Cardiol. 2016 Jun 21;67(24):2888-99
25677422 - J Am Coll Cardiol. 2015 Feb 24;65(7):635-42
23850908 - J Am Coll Cardiol. 2013 Sep 24;62(13):1187-92
24595776 - JAMA. 2014 Mar 5;311(9):919-28
23553523 - Circ Arrhythm Electrophysiol. 2013 Jun;6(3):460-6
12907817 - Stroke. 2003 Sep;34(9):2091-6
24810388 - Eur Heart J. 2014 Jul 21;35(28):1844-55
27033342 - Heart Rhythm. 2016 Aug;13(8):1581-8
22572202 - Lancet Neurol. 2012 Jun;11(6):503-11
23482602 - Stroke. 2013 May;44(5):1226-31
8572814 - Ann Thorac Surg. 1996 Feb;61(2):755-9
27890386 - J Formos Med Assoc. 2016 Nov;115(11):893-952
26105732 - Europace. 2015 Aug;17 (8):1197-214
21646496 - Circulation. 2011 Jun 28;123(25):2946-53
25501800 - Circ J. 2015;79(2):432-8
27535163 - Expert Opin Drug Metab Toxicol. 2016 Dec;12 (12 ):1445-1461
27289185 - J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2215-21
26214205 - Am J Ther. 2016 Mar-Apr;23 (2):e474-84
23525418 - J Am Heart Assoc. 2013 Feb 19;2(1):e000067
23212720 - Circulation. 2013 Jan 15;127(2):224-32
8534685 - Adv Perit Dial. 1995;11:127-30
26095867 - N Engl J Med. 2015 Aug 27;373(9):823-33
22115643 - J Am Coll Cardiol. 2011 Nov 29;58(23):2380-5
26307106 - Pol Arch Med Wewn. 2015 ;125(9):666-71
16442406 - Am J Cardiol. 2006 Feb 1;97(3):409-11
28317415 - N Engl J Med. 2017 Apr 27;376(17 ):1627-1636
21972820 - J Thromb Haemost. 2011 Nov;9(11):2168-75
26095746 - N Engl J Med. 2015 Aug 6;373(6):511-20
26361166 - J Am Coll Cardiol. 2015 Sep 15;66(11):1310-1
19915883 - Clin Res Cardiol. 2010 Feb;99(2):125-8
21200007 - Circulation. 2011 Jan 18;123(2):131-6
22271713 - Circ Arrhythm Electrophysiol. 2012 Apr;5(2):302-11
24975193 - Can J Cardiol. 2014 Aug;30(8):853-4
20516376 - Circulation. 2010 Jun 15;121(23):2550-6
24054920 - Can J Cardiol. 2013 Nov;29(11):1443-7
21139092 - Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):14-21
24610776 - Circ Arrhythm Electrophysiol. 2014 Apr;7(2):300-6
25368205 - Eur Heart J. 2015 Feb 1;36(5):307-14a
26383720 - J Am Coll Cardiol. 2015 Sep 22;66(12):1339-47
22137743 - Thromb Res. 2012 Jul;130(1):21-6
25777547 - Biochemistry. 2015 Apr 7;54(13):2227-39
25501801 - Circ J. 2015;79(2):339-45
24595773 - JAMA. 2014 Mar 5;311(9):913-5
23524209 - J Am Coll Cardiol. 2013 May 21;61(20):2079-87
22118827 - Am J Cardiol. 2012 Feb 1;109(3):378-82
17100983 - Br J Clin Pharmacol. 2007 Apr;63(4):469-76
25182247 - Eur Heart J. 2014 Dec 14;35(47):3346-55
15831779 - J Clin Pharmacol. 2005 May;45(5):555-63
18757287 - Stroke. 2009 Jan;40(1):235-40
20569726 - Am Heart J. 2010 Jun;159(6):1102-7
23625942 - Europace. 2013 May;15(5):625-51
23305158 - Br J Clin Pharmacol. 2013 Sep;76(3):455-66
25523529 - JACC Cardiovasc Interv. 2014 Dec;7(12):1333-51
25154388 - Eur Heart J. 2014 Dec 1;35(45):3155-79
1866765 - Stroke. 1991 Aug;22(8):983-8
21309657 - N Engl J Med. 2011 Mar 3;364(9):806-17
22319004 - Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26
25173541 - Am Heart J. 2014 Sep;168(3):303-9
26460886 - Circ J. 2015;79(12):2560-7
27625386 - Stroke. 2016 Oct;47(10 ):2462-9
27010633 - PLoS One. 2016 Mar 24;11(3):e0150674
11346805 - N Engl J Med. 2001 May 10;344(19):1411-20
25323252 - J Am Coll Cardiol. 2014 Oct 21;64(16):1658-65
25406148 - Stroke. 2015 Jan;46(1):23-30
19762550 - Chest. 2010 Feb;137(2):263-72
1
References_xml – volume: 61
  start-page: 1998
  year: 2013
  end-page: 2006
  article-title: Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial
  publication-title: J Am Coll Cardiol
– volume: 369
  start-page: 1206
  year: 2013
  end-page: 1214
  article-title: Dabigatran versus warfarin in patients with mechanical heart valves
  publication-title: N Engl J Med
– volume: 113
  start-page: 931
  year: 2015
  end-page: 942
  article-title: Reversal of anticoagulants: an overview of current developments
  publication-title: Thromb Haemost
– volume: 40
  start-page: 926
  year: 2002
  end-page: 933
  article-title: Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
  publication-title: J Am Coll Cardiol
– volume: 29
  start-page: 1443
  year: 2013
  end-page: 1447
  article-title: Left atrial appendage occlusion study II (LAAOS II)
  publication-title: Can J Cardiol
– volume: 45
  start-page: 1739
  year: 2014
  end-page: 1747
  article-title: Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial
  publication-title: Stroke
– volume: 30
  start-page: 1726
  year: 2008
  end-page: 1736
  article-title: Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation‐A nationwide descriptive study in Taiwan
  publication-title: Clin Ther
– volume: 97
  start-page: 409
  year: 2006
  end-page: 411
  article-title: Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin‐related over‐anticoagulation in patients with mechanical heart valves
  publication-title: Am J Cardiol
– volume: 79
  start-page: 1009
  year: 2015
  end-page: 1017
  article-title: Low body weight is associated with the incidence of stroke in atrial fibrillation patients‐ insight from the Fushimi AF registry
  publication-title: Circ J
– volume: 32
  start-page: 2387
  year: 2011
  end-page: 2394
  article-title: Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non‐valvular atrial fibrillation and moderate renal impairment
  publication-title: Eur Heart J
– volume: 69
  start-page: 546
  year: 2007
  end-page: 554
  article-title: Independent predictors of stroke in patients with atrial fibrillation: a systematic review
  publication-title: Neurology
– volume: 138
  start-page: 1093
  year: 2010
  end-page: 1100
  article-title: A novel user‐friendly score (HAS‐BLED) To assess 1‐year risk of major bleeding in patients with atrial fibrillation
  publication-title: Chest
– volume: 18
  start-page: 109
  year: 1977
  end-page: 113
  article-title: The risk of anticoagulation in hemodialysis patients
  publication-title: Nephron
– volume: 82
  start-page: 283
  year: 2013
  end-page: 289
  article-title: Amplatzer left atrial appendage occlusion: single center 10‐year experience
  publication-title: Catheter Cardiovasc Interv
– volume: 104
  start-page: 1551
  year: 2009
  end-page: 1555
  article-title: Relation of kidney function and albuminuria with atrial fibrillation (from the heart and soul study)
  publication-title: Am J Cardiol
– volume: 6
  start-page: 24376
  year: 2016
  article-title: Major bleeding in patients with non‐valvular atrial fibrillation: impact of time in therapeutic range on contemporary bleeding risk scores
  publication-title: Sci Rep
– volume: 154
  start-page: 1449
  year: 1994
  end-page: 1457
  article-title: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
  publication-title: Arch Intern Med
– volume: 61
  start-page: 873
  year: 2005
  end-page: 880
  article-title: Safety, pharmacodynamics, and pharmacokinetics of BAY 59‐7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
  publication-title: Eur J Clin Pharmacol
– volume: 58
  start-page: 2380
  year: 2011
  end-page: 2385
  article-title: CHADS2 and CHA2DS2‐VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation
  publication-title: J Am Coll Cardiol
– volume: 77
  start-page: 700
  year: 2011
  end-page: 706
  article-title: Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience
  publication-title: Catheter Cardiovasc Interv
– volume: 370
  start-page: 2467
  year: 2014
  end-page: 2477
  article-title: Atrial fibrillation in patients with cryptogenic stroke
  publication-title: N Engl J Med
– volume: 165
  start-page: 1095
  year: 2005
  end-page: 1106
  article-title: Systematic overview of warfarin and its drug and food interactions
  publication-title: Arch Intern Medi
– volume: 114
  start-page: 646
  year: 2014
  end-page: 653
  article-title: Meta‐analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation
  publication-title: Am J Cardiol
– volume: 180
  start-page: 246
  year: 2015
  end-page: 254
  article-title: Non‐vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal
  publication-title: Int J Cardiol
– volume: 87
  start-page: 1209
  year: 2015
  end-page: 1215
  article-title: Incidence and risk factors for new‐onset atrial fibrillation among patients with end‐stage renal disease undergoing renal replacement therapy
  publication-title: Kidney Int
– volume: 30
  start-page: 853
  year: 2014
  end-page: 854
  article-title: Oral anticoagulant use in patients with chronic kidney disease: how to choose, and the importance of empiric human data
  publication-title: Can J Cardiol
– volume: 36
  start-page: 297
  year: 2014
  end-page: 306
  article-title: Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
  publication-title: Eur Heart J
– volume: 338
  start-page: 372
  year: 2011
  end-page: 380
  article-title: In vitro and in vivo P‐glycoprotein transport characteristics of rivaroxaban
  publication-title: J Pharmacol Exp Ther
– volume: 77
  start-page: 1098
  year: 2010
  end-page: 1106
  article-title: Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
  publication-title: Kidney Int
– volume: 373
  start-page: 511
  year: 2015
  end-page: 520
  article-title: Idarucizumab for dabigatran reversal
  publication-title: N Engl J Med
– volume: 63
  start-page: 1082
  year: 2014
  end-page: 1087
  article-title: Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation)
  publication-title: J Am Coll Cardiol
– volume: 285
  start-page: 2864
  year: 2001
  end-page: 2870
  article-title: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation
  publication-title: JAMA
– volume: 46
  start-page: 2555
  year: 2015
  end-page: 2561
  article-title: Non‐Vitamin K antagonist oral anticoagulants for stroke prevention in asian patients with nonvalvular atrial fibrillation: meta‐analysis
  publication-title: Stroke
– volume: 11
  start-page: 503
  year: 2012
  end-page: 511
  article-title: Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
  publication-title: Lancet Neurol
– volume: 188
  start-page: 669
  year: 2016
  end-page: 672
  article-title: Bleeding associated with coadministration of rivaroxaban and clarithromycin
  publication-title: CMAJ
– volume: 127
  start-page: 169
  year: 2013
  end-page: 171
  article-title: “R” for “renal” and for “risk”: refining risk stratification for stroke in atrial fibrillation
  publication-title: Circulation
– volume: 38
  start-page: 1674
  year: 2016
  end-page: 1685
  article-title: Evaluation of crushed tablet for oral administration and the effect of food on apixaban pharmacokinetics in healthy adults
  publication-title: Clin Ther
– volume: 62
  start-page: 212
  year: 2013
  end-page: 221
  article-title: The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor
  publication-title: J Cardiovasc Pharmacol
– volume: 36
  start-page: 3258
  year: 2015
  end-page: 3264
  article-title: The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
  publication-title: Eur Heart J
– volume: 121
  start-page: 2550
  year: 2010
  end-page: 2556
  article-title: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation
  publication-title: Impact Periprocedural Ther Int Norm Ratio Circ
– volume: 35
  start-page: 447
  year: 2015
  end-page: 453
  article-title: The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
  publication-title: Clin Drug Investig
– volume: 351
  start-page: h2391
  year: 2015
  article-title: Peri‐procedural management of patients taking oral anticoagulants
  publication-title: BMJ
– volume: 119
  start-page: 142
  year: 2006
  end-page: 146
  article-title: Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic‐guided cardioversion
  publication-title: Am J Med
– volume: 10
  start-page: 483
  year: 2013
  end-page: 489
  article-title: Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
  publication-title: Heart Rhythm
– volume: 61
  start-page: 2551
  year: 2013
  end-page: 2556
  article-title: Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP Study (ASA plavix feasibility study with watchman left atrial appendage closure technology)
  publication-title: J Am Coll Cardiol
– volume: 33
  start-page: 1500
  year: 2012
  end-page: 1510
  article-title: Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
  publication-title: Eur Heart J
– volume: 13
  start-page: 2340
  year: 2016
  end-page: 2347
  article-title: Standard dose versus low dose non–vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: a meta‐analysis of contemporary randomized controlled trials
  publication-title: Heart Rhythm
– volume: 37
  start-page: 447
  year: 2006
  end-page: 451
  article-title: Low‐dose aspirin for prevention of stroke in low‐risk patients with atrial fibrillation: japan atrial fibrillation stroke trial
  publication-title: Stroke
– volume: 2
  start-page: e000250
  year: 2013
  article-title: A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score
  publication-title: J Am Heart Assoc
– volume: 135
  start-page: 1273
  year: 2017
  end-page: 1275
  article-title: Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves
  publication-title: Circulation
– volume: 21
  start-page: 35
  year: 2001
  end-page: 39
  article-title: Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation
  publication-title: Am J Nephrol
– volume: 344
  start-page: 1411
  year: 2001
  end-page: 1420
  article-title: Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 78
  start-page: 908
  year: 2014
  end-page: 917
  article-title: Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care – results from the Dresden NOAC registry
  publication-title: Br J Clin Pharmacol
– volume: 9
  start-page: 632
  year: 2012
  end-page: 696
  article-title: 2012 h/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow‐up, definitions, endpoints, and research trial design: a report of the heart rhythm society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
  publication-title: Heart Rhythm
– volume: 82
  start-page: 1545
  year: 1998
  end-page: 1547
  article-title: Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis
  publication-title: Am J Cardiol
– volume: 34
  start-page: 2091
  year: 2003
  end-page: 2096
  article-title: Proportion of different subtypes of stroke in China
  publication-title: Stroke
– volume: 35
  start-page: 3346
  year: 2014
  end-page: 3355
  article-title: Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
  publication-title: Eur Heart J
– volume: 2014
  start-page: 2071
  issue: (130)
  year: 2014
  end-page: 2104
  article-title: AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
  publication-title: Circulation
– volume: 365
  start-page: 883
  year: 2011
  end-page: 891
  article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
  publication-title: N Engl J Med
– volume: 25
  start-page: 2215
  year: 2016
  end-page: 2221
  article-title: Perioperative heparin bridging in atrial fibrillation patients requiring temporary interruption of anticoagulation: evidence from meta‐analysis
  publication-title: J Stroke Cerebrovasc Dis
– volume: 31
  start-page: 1207
  year: 2015
  end-page: 1218
  article-title: The 2014 atrial fibrillation guidelines companion: a practical approach to the use of the Canadian cardiovascular society guidelines
  publication-title: Can J Cardiol
– volume: 387
  start-page: 2302
  year: 2016
  end-page: 2311
  article-title: The novel biomarker‐based ABC (age, biomarkers, clinical history)‐bleeding risk score for patients with atrial fibrillation: a derivation and validation study
  publication-title: Lancet
– volume: 79
  start-page: 2560
  year: 2015
  end-page: 2567
  article-title: Effects of regional differences in asia on efficacy and safety of edoxaban compared with warfarin‐insights from the ENGAGE AF‐TIMI 48 trial
  publication-title: Circ J
– volume: 64
  start-page: 585
  year: 2014
  end-page: 587
  article-title: Switching patients from blinded study drug to warfarin at the end of the ENGAGE AF–TIMI 48 trial: setting a new standard
  publication-title: J Am Coll Cardiol
– volume: 140
  start-page: 150
  year: 2000
  end-page: 156
  article-title: Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study
  publication-title: Am Heart J
– volume: 6
  start-page: e65
  year: 2013
  article-title: Letter by May et al. regarding article, “Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation” by Bassiouny et al
  publication-title: Circ Arrhythm Electrophysiol
– volume: 79
  start-page: 339
  year: 2015
  end-page: 345
  article-title: Efficacy and safety of non‐vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation‐meta‐analysis
  publication-title: Circ J
– volume: 43
  start-page: 1511
  year: 2012
  end-page: 1517
  article-title: Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE‐LY trial
  publication-title: Stroke
– volume: 376
  start-page: 975
  year: 2010
  end-page: 983
  article-title: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE‐LY trial
  publication-title: Lancet
– volume: 151
  start-page: 713
  year: 2006
  end-page: 719
  article-title: Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF)
  publication-title: Am Heart J
– volume: 222
  start-page: 47
  year: 2016
  end-page: 50
  article-title: Atrial fibrillation and chronic kidney disease requiring hemodialysis — does warfarin therapy improve the risks of this lethal combination?
  publication-title: Int J Cardiol
– volume: 134
  start-page: 24
  year: 2016
  end-page: 36
  article-title: Impact of renal function on outcomes with edoxaban in the ENGAGE AF‐TIMI 48 trial
  publication-title: Circulation
– volume: 50
  start-page: 433
  year: 2007
  end-page: 440
  article-title: Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates
  publication-title: Am J Kidney Dis
– volume: 69
  start-page: 1363
  year: 2017
  end-page: 1371
  article-title: Non–Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease
  publication-title: J Am Coll Cardiol
– volume: 11
  start-page: e0150674
  year: 2016
  article-title: Use of the SAMe‐TT2R2 score to predict good anticoagulation control with warfarin in Chinese patients with atrial fibrillation: relationship to ischemic stroke incidence
  publication-title: PLoS One
– volume: 46
  start-page: 23
  year: 2015
  end-page: 30
  article-title: Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control
  publication-title: Stroke
– volume: 342
  start-page: d124
  year: 2011
  article-title: Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
  publication-title: BMJ
– volume: 374
  start-page: 534
  year: 2009
  end-page: 542
  article-title: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non‐inferiority trial
  publication-title: Lancet
– volume: 40
  start-page: 140
  year: 2015
  end-page: 145
  article-title: Relevance of P‐glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban
  publication-title: Herz
– volume: 388
  start-page: 806
  year: 2016
  end-page: 817
  article-title: Stroke prevention in atrial fibrillation
  publication-title: Lancet
– volume: 48
  start-page: 1
  year: 2009
  end-page: 22
  article-title: Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development
  publication-title: Clin Pharmacokinet
– volume: 144
  start-page: 1555
  year: 2013
  end-page: 1563
  article-title: Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe‐TT2R2 score
  publication-title: Chest
– volume: 131
  start-page: 2176
  year: 2015
  end-page: 2184
  article-title: Mass screening for untreated atrial fibrillation: the STROKESTOP study
  publication-title: Circulation
– volume: 123
  start-page: 2946
  year: 2011
  end-page: 2953
  article-title: Chronic kidney disease is associated with the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study
  publication-title: Circulation
– volume: 127
  start-page: 224
  year: 2013
  end-page: 232
  article-title: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (rivaroxaban once‐daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) and ATRIA (AnTicoagulation and risk factors in atrial fibrillation) study cohorts
  publication-title: Circulation
– volume: 168
  start-page: 303
  year: 2014
  end-page: 309
  article-title: Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) Trial
  publication-title: Am Heart J
– volume: 21
  start-page: 230
  year: 1990
  end-page: 235
  article-title: Cerebrovascular disease in Hong Kong Chinese
  publication-title: Stroke
– volume: 47
  start-page: 2075
  year: 2016
  end-page: 2082
  article-title: Outcomes with edoxaban versus warfarin in patients with previous cerebrovascular events. Findings from ENGAGE AF‐TIMI 48 (effective anticoagulation with factor Xa next generation in atrial fibrillation‐thrombolysis in myocardial infarction 48)
  publication-title: Stroke
– volume: 6
  start-page: 2599
  year: 2011
  end-page: 2604
  article-title: Warfarin in atrial fibrillation patients with moderate chronic kidney disease
  publication-title: Clin J Am Soci Nephrol
– volume: 367
  start-page: 625
  year: 2012
  end-page: 635
  article-title: Stroke and bleeding in atrial fibrillation with chronic kidney disease
  publication-title: N Engl J Med
– volume: 99
  start-page: 125
  year: 2010
  end-page: 128
  article-title: Should transesophageal echocardiography be done in all patients who underwent catheter ablation of atrial fibrillation? A case report and review of the literature
  publication-title: Clin Res Cardiol
– volume: 101
  start-page: 877
  year: 2015
  end-page: 883
  article-title: Two‐year clinical outcome from the Iberian registry patients after left atrial appendage closure
  publication-title: Heart
– volume: 146
  start-page: 857
  year: 2007
  end-page: 867
  article-title: Meta‐analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
  publication-title: Ann Intern Med
– volume: 61
  start-page: 651
  year: 2013
  end-page: 658
  article-title: Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban once‐daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)
  publication-title: J Am Coll Cardiol
– volume: 25
  start-page: 341
  year: 2012
  end-page: 353
  article-title: Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis
  publication-title: J Nephrol
– volume: 15
  start-page: 625
  year: 2013
  end-page: 651
  article-title: European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non‐valvular atrial fibrillation
  publication-title: Europace
– volume: 11
  start-page: 791
  year: 2014
  end-page: 798
  article-title: Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study
  publication-title: Heart Rhythm
– volume: 107
  start-page: 77
  year: 2014
  end-page: 87
  article-title: Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey
  publication-title: Arch Cardiovasc Dis
– year: 2014
  article-title: Edoxaban versus warfarin in East‐Asian (Including Japanese) patients with atrial fibrillation―an ENGAGE AF‐TIMI 48 Sub‐analysis
  publication-title: Circ J
– volume: 45
  start-page: 555
  year: 2005
  end-page: 565
  article-title: Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
  publication-title: J Clin Pharmacol
– volume: 130
  start-page: 21
  year: 2012
  end-page: 26
  article-title: Clinical outcome in Japanese elderly patients with non‐valvular atrial fibrillation taking warfarin: a single‐center observational study
  publication-title: Thromb Res
– volume: 35
  start-page: 1888
  year: 2014
  end-page: 1896
  article-title: Peri‐interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
  publication-title: Eur Heart J
– volume: 150
  start-page: 288
  year: 2005
  end-page: 293
  article-title: Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke
  publication-title: Am Heart J
– volume: 76
  start-page: 107
  year: 2013
  end-page: 113
  article-title: A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin
  publication-title: Br J Clin Pharmacol
– volume: 137
  start-page: 263
  year: 2010
  end-page: 272
  article-title: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor‐based approach: the euro heart survey on atrial fibrillation
  publication-title: Chest
– volume: 59
  start-page: 1413
  year: 2012
  end-page: 1425
  article-title: New oral anticoagulants in atrial fibrillation and acute coronary syndromes: esc working group on thrombosis‐task force on anticoagulants in heart disease position paper
  publication-title: J Am Coll Cardiol
– volume: 313
  start-page: 824
  year: 2015
  end-page: 836
  article-title: ANticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation‐related intracerebral hemorrhage
  publication-title: JAMA
– volume: 77
  start-page: 897
  year: 2002
  end-page: 904
  article-title: Safety of electrical cardioversion in patients with atrial fibrillation
  publication-title: Mayo Clin Proc
– volume: 125
  start-page: 666
  year: 2015
  end-page: 671
  article-title: Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials
  publication-title: Pol Arch Med Wewn
– volume: 110
  start-page: 694
  year: 2001
  end-page: 702
  article-title: Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short‐term safety and impact on maintenance of sinus rhythm at 1 year
  publication-title: Am J Med
– volume: 11
  start-page: 1401
  year: 2014
  end-page: 1408
  article-title: Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong
  publication-title: Heart Rhythm
– volume: 64
  start-page: 1
  year: 2014
  end-page: 12
  article-title: Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long‐term warfarin therapy: the PREVAIL trial
  publication-title: J Am Colle Cardiol
– volume: 76
  start-page: 455
  year: 2013
  end-page: 466
  article-title: Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
  publication-title: Br J Clin Pharmacol
– volume: 36
  start-page: 307
  year: 2015
  end-page: 315
  article-title: Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long‐term follow‐up in nationwide cohort of Denmark
  publication-title: Eur Heart J
– volume: 13
  start-page: 1581
  year: 2016
  end-page: 1588
  article-title: Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: a population‐wide cohort study
  publication-title: Heart Rhythm
– volume: 120
  start-page: 2954
  year: 2012
  end-page: 2962
  article-title: How I treat anticoagulated patients undergoing an elective procedure or surgery
  publication-title: Blood
– volume: 34
  start-page: 586
  year: 2016
  end-page: 599
  article-title: Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy
  publication-title: J Clin Anesth
– volume: 9
  start-page: 1157
  year: 2010
  end-page: 1163
  article-title: Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE‐LY trial
  publication-title: Lancet Neurol
– volume: 23
  start-page: e474
  year: 2016
  end-page: e484
  article-title: Perioperative management of anticoagulation‐review of latest evidence
  publication-title: Am J Ther
– volume: 121
  start-page: 3554
  year: 2013
  end-page: 3562
  article-title: A specific antidote for dabigatran: functional and structural characterization
  publication-title: Blood
– volume: 111
  start-page: 781
  year: 2014
  end-page: 782
  article-title: Non‐vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel
  publication-title: Thromb Haemost
– volume: 52
  start-page: 924
  year: 2008
  end-page: 929
  article-title: Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography
  publication-title: J Am Coll Cardiol
– volume: 375
  start-page: 2423
  year: 2016
  end-page: 2434
  article-title: Prevention of Bleeding in Patients with atrial fibrillation undergoing PCI
  publication-title: N Engl J Med
– volume: 376
  start-page: 1627
  year: 2017
  end-page: 1636
  article-title: Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation
  publication-title: N Engl J Med
– volume: 44
  start-page: 525
  year: 2014
  end-page: 536
  article-title: New oral anticoagulants: a practical guide on prescription, laboratory testing and peri‐procedural/bleeding management
  publication-title: Intern Med J
– volume: 26
  start-page: 64
  year: 2017
  end-page: 69
  article-title: The sex, age, medical history, treatment, tobacco use, race risk (SAMe TT2R2) score predicts warfarin control in a Singaporean population
  publication-title: J Stroke Cerebrovasc Dis
– volume: 22
  start-page: 1910
  year: 2007
  end-page: 1915
  article-title: Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population—the Ohasama study
  publication-title: Nephrol Dial Transplant
– volume: 62
  start-page: 108
  year: 2013
  end-page: 118
  article-title: Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience
  publication-title: J Am Coll Cardiol
– volume: 132
  start-page: 517
  year: 2015
  end-page: 525
  article-title: Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study
  publication-title: Circulation
– volume: 6
  start-page: 220
  year: 2010
  end-page: 226
  article-title: PLAATO (Percutaneous left atrial appendage transcatheter occlusion) for prevention of cardioembolic stroke in non‐anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study
  publication-title: EuroIntervention
– volume: 13
  start-page: 46
  year: 2016
  end-page: 53
  article-title: Comparisons of CHADS2 and CHA2DS2‐VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians?
  publication-title: Heart Rhythm
– volume: 26
  start-page: 103
  year: 2013
  end-page: 114
  article-title: Disadvantages of VKA and requirements for novel anticoagulants
  publication-title: Best Pract Res Clin Haematol
– volume: 383
  start-page: 931
  year: 2014
  end-page: 933
  article-title: Warfarin or novel oral anticoagulants for atrial fibrillation?
  publication-title: Lancet
– volume: 149
  start-page: 951
  year: 2016
  end-page: 959
  article-title: Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta‐analysis of observational studies
  publication-title: Chest
– volume: 12
  start-page: 1445
  year: 2016
  end-page: 1461
  article-title: Drug‐drug interactions of non‐vitamin K oral anticoagulants
  publication-title: Expert Opin Drug Metab Toxicol
– volume: 126
  start-page: 343
  year: 2012
  end-page: 348
  article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long‐term anticoagulation therapy (RE‐LY) randomized trial
  publication-title: Circulation
– volume: 126
  start-page: 615
  year: 1997
  end-page: 620
  article-title: RIsk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours
  publication-title: Ann Intern Med
– volume: 373
  start-page: 2413
  year: 2015
  end-page: 2424
  article-title: Andexanet alfa for the reversal of factor Xa inhibitor activity
  publication-title: N Engl J Med
– volume: 18
  start-page: 1308
  year: 2016
  end-page: 1318
  article-title: Antithrombotic therapy use in patients with atrial fibrillation before the era of non‐vitamin K antagonist oral anticoagulants: the global registry on long‐term oral antithrombotic treatment in patients with atrial fibrillation (GLORIA‐AF)phase I cohort
  publication-title: Europace
– volume: 111
  start-page: 933
  year: 2014
  end-page: 942
  article-title: Patient outcomes using the European label for dabigatran. A post‐hoc analysis from the RE‐LY database
  publication-title: Thromb Haemost
– volume: 18
  start-page: 665
  year: 2016
  end-page: 671
  article-title: Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
  publication-title: Europace
– volume: 39
  start-page: 841
  year: 2016
  end-page: 845
  article-title: Drug Interactions of direct‐acting oral anticoagulants
  publication-title: Drug Saf
– volume: 66
  start-page: 1339
  year: 2015
  end-page: 1347
  article-title: Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study From Taiwan
  publication-title: J Am Coll Cardiol
– volume: 6
  start-page: 2662
  year: 2011
  end-page: 2668
  article-title: Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation
  publication-title: Clin J Am Soc Nephrol
– volume: 17
  start-page: 38
  year: 1991
  end-page: 42
  article-title: Effect of hemodialysis on protein C, protein S, and antithrombin III levels
  publication-title: Am J Kidney Dis
– volume: 56
  start-page: 271
  year: 1990
  end-page: 276
  article-title: Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis
  publication-title: Nephron
– volume: 32
  start-page: 995
  year: 2009
  end-page: 999
  article-title: Atrial fibrillation ablation in patients with therapeutic international normalized ratios
  publication-title: Pacing Clin Electrophysiol
– volume: 19
  start-page: 446
  year: 2013
  end-page: 451
  article-title: A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
  publication-title: Nat Med
– volume: 6
  start-page: 1063
  year: 2007
  end-page: 1072
  article-title: Risk of stroke early after transient ischaemic attack: a systematic review and meta‐analysis
  publication-title: Lancet Neurol
– volume: 124
  start-page: 3692
  year: 2014
  end-page: 3698
  article-title: Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
  publication-title: Blood
– volume: 11
  start-page: 315
  year: 2012
  end-page: 322
  article-title: Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
  publication-title: Lancet Neurol
– volume: 24
  start-page: 2613
  year: 2015
  end-page: 2618
  article-title: Impact of sex difference on severity and functional outcome in patients with cardioembolic stroke
  publication-title: J Stroke Cerebrovasc Dis
– volume: 35
  start-page: 1736
  year: 2015
  end-page: 1745
  article-title: Antidotes for novel oral anticoagulants. current status and future potential
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 13
  start-page: 2053
  year: 1998
  end-page: 2058
  article-title: Effect of increasing serum albumin on haemostatic factors synthesized in the liver in CAPD patients
  publication-title: Nephrol Dial Transplant
– volume: 129
  start-page: 1568
  year: 2014
  end-page: 1576
  article-title: Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE‐LY atrial fibrillation registry
  publication-title: Circulation
– volume: 118
  start-page: 1466
  year: 2013
  end-page: 1474
  article-title: Managing new oral anticoagulants in the perioperative and intensive care unit setting
  publication-title: Anesthesiology
– volume: 15
  start-page: 276
  year: 2004
  end-page: 283
  article-title: High‐flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the left atrium
  publication-title: J Cardiovasc Electrophysiol
– volume: 132
  start-page: 624
  year: 2015
  end-page: 632
  article-title: Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial
  publication-title: Circulation
– volume: 61
  start-page: 2079
  year: 2013
  end-page: 2087
  article-title: Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the loire valley atrial fibrillation project
  publication-title: J Am Coll Cardiol
– volume: 129
  start-page: 600
  year: 2016
  end-page: 607
  article-title: Evaluation of the HAS‐BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin
  publication-title: Am J Med
– volume: 127
  start-page: 569
  year: 2013
  end-page: 574
  article-title: Incident atrial fibrillation and risk of end‐stage renal disease in adults with chronic kidney disease
  publication-title: Circulation
– volume: 19
  start-page: 1
  year: 2012
  end-page: 7
  article-title: The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia
  publication-title: Malays J Med Sci
– volume: 15
  start-page: 9S
  issue: (Suppl 1)
  year: 2009
  end-page: 16S
  article-title: Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor
  publication-title: Clin Appl Thromb Hemost
– volume: 4
  start-page: e002322
  year: 2015
  article-title: Dabigatran is less effective than warfarin at attenuating mechanical heart valve‐induced thrombin generation
  publication-title: J Am Heart Assoc
– volume: 63
  start-page: 469
  year: 2007
  end-page: 476
  article-title: Rivaroxaban (BAY 59‐7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxen
  publication-title: Br J Clin Pharmacol
– volume: 45
  start-page: 1304
  year: 2014
  end-page: 1312
  article-title: Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation
  publication-title: Stroke
– volume: 14
  start-page: 875
  year: 2016
  end-page: 885
  article-title: Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery
  publication-title: J Thromb Haemost
– volume: 66
  start-page: 1310
  year: 2015
  end-page: 1311
  article-title: Clinical benefit of warfarin in dialysis patients with atrial fibrillation
  publication-title: J Am Coll Cardiol
– volume: 20
  start-page: 1357
  year: 2009
  end-page: 1363
  article-title: Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation
  publication-title: J Cardiovasc Electrophysiol
– volume: 388
  start-page: 1995
  year: 2016
  end-page: 2003
  article-title: Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE‐AF): a randomised, open‐label, phase 3b trial
  publication-title: Lancet
– volume: 2016
  start-page: 1609
  issue: (18)
  year: 2016
  end-page: 1678
  article-title: ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
  publication-title: Europace
– volume: 14
  start-page: 1711
  year: 2016
  end-page: 1714
  article-title: Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
  publication-title: J Thromb Haemost
– volume: 32
  start-page: 1381
  year: 2016
  end-page: 1387
  article-title: CHA2DS2‐VASc recalibration with an additional age category (50‐64 Years) enhances stroke risk stratification in Chinese patients with atrial fibrillation
  publication-title: Can J Cardiol
– volume: 65
  start-page: 635
  year: 2015
  end-page: 642
  article-title: Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2‐VASc score (Beyond Sex) receive oral anticoagulation?
  publication-title: J Am Coll Cardiol
– volume: 312
  start-page: 1988
  year: 2014
  end-page: 1998
  article-title: Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial
  publication-title: JAMA
– volume: 5
  start-page: 319
  year: 2012
  end-page: 326
  article-title: Reliable identification of “truly low” thromboembolic risk in patients initially diagnosed with “lone” atrial fibrillation: the Belgrade atrial fibrillation study
  publication-title: Circ Arrhythm Electrophysiol
– volume: 78
  start-page: 2367
  year: 2014
  end-page: 2372
  article-title: Impact of non‐vitamin K antagonist oral anticoagulants on intracranial bleeding in Asian patients with non‐valvular atrial fibrillation
  publication-title: Circ J
– volume: 4
  start-page: 26
  year: 2011
  end-page: 32
  article-title: Association of chronic kidney disease with atrial fibrillation among adults in the United States: reasons for geographic and racial differences in stroke (REGARDS) study
  publication-title: Circ Arrhythm Electrophysiol
– volume: 2012
  start-page: 2719
  issue: (33)
  year: 2012
  end-page: 2747
  article-title: focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the American College of Cardiology
  publication-title: Eur Heart J
– volume: 80
  start-page: 161
  year: 1995
  end-page: 168
  article-title: Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S
  publication-title: Thromb Res
– volume: 361
  start-page: 1139
  year: 2009
  end-page: 1151
  article-title: Dabigatran versus warfarin in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 35
  start-page: 3155
  year: 2014
  end-page: 3179
  article-title: Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia‐Pacific Heart Rhythm Society (APHRS)
  publication-title: Eur Heart J
– volume: 133
  start-page: 1540
  year: 2016
  end-page: 1547
  article-title: Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage
  publication-title: Circulation
– volume: 66
  start-page: 488
  year: 2015
  end-page: 490
  article-title: Net clinical benefit for oral anticoagulation, aspirin, or no therapy in nonvalvular atrial fibrillation patients with 1 additional risk factor of the CHA2DS2‐VASc score (Beyond Sex)
  publication-title: J Am Coll Cardiol
– volume: 16
  start-page: 31
  year: 1976
  end-page: 41
  article-title: Prediction of creatinine clearance from serum creatinine
  publication-title: Nephron
– volume: 47
  start-page: 2197
  year: 2016
  end-page: 2202
  article-title: Global survey of the frequency of atrial fibrillation–associated stroke. Embolic stroke of undetermined source global registry
  publication-title: Stroke
– volume: 133
  start-page: 265
  year: 2016
  end-page: 272
  article-title: Risks of death and stroke in patients undergoing hemodialysis with new‐onset atrial fibrillation: a competing‐risk analysis of a nationwide cohort
  publication-title: Circulation
– volume: 44
  start-page: 1891
  year: 2013
  end-page: 1896
  article-title: Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and Non‐Asians with atrial fibrillation
  publication-title: Stroke
– volume: 69
  start-page: 1372
  year: 2017
  end-page: 1382
  article-title: Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF‐TIMI 48 Trial
  publication-title: J Am Coll Cardiol
– volume: 10
  start-page: 692
  year: 2012
  end-page: 694
  article-title: Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy
  publication-title: J Thromb Haemost
– volume: 68
  start-page: 1452
  year: 2016
  end-page: 1464
  article-title: Atrial fibrillation and thromboembolism in patients with chronic kidney disease
  publication-title: J Am Coll Cardiol
– volume: 18
  start-page: 988
  year: 2012
  end-page: 993
  article-title: One‐year clinical prediction in Chinese ischemic stroke patients using the CHADS2 and CHA2DS2‐VASc scores: the China National Stroke Registry
  publication-title: CNS Neurosci Ther
– volume: 2016
  start-page: 893
  issue: (115)
  year: 2016
  end-page: 952
  article-title: Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
  publication-title: J Formos Med Assoc
– volume: 40
  start-page: 235
  year: 2009
  end-page: 240
  article-title: Potentially preventable strokes in high‐risk patients with atrial fibrillation who are not adequately anticoagulated
  publication-title: Stroke
– volume: 111
  start-page: 789
  year: 2014
  end-page: 797
  article-title: Stroke prevention in atrial fibrillation: an Asian perspective
  publication-title: Thromb Haemost
– volume: 61
  start-page: 755
  year: 1996
  end-page: 759
  article-title: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
  publication-title: Ann Thorac Surg
– volume: 34
  start-page: 3572
  year: 2013
  end-page: 3579
  article-title: Renal function and outcomes in anticoagulated patients with non‐valvular atrial fibrillation: the AMADEUS trial
  publication-title: Eur Heart J
– volume: 80
  start-page: 572
  year: 2011
  end-page: 586
  article-title: Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO)
  publication-title: Kidney Int
– volume: 17
  start-page: 1197
  year: 2015
  end-page: 1214
  article-title: Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC working group thrombosis, heart rhythm society (HRS), and Asia Pacific heart rhythm society (APHRS)
  publication-title: Europace
– volume: 17
  start-page: 303
  year: 2004
  end-page: 313
  article-title: Incidence of cerebral hemorrhage in the Changsha community
  publication-title: Cerebrovasc Dis
– volume: 7
  start-page: 300
  year: 2014
  end-page: 306
  article-title: Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol
– volume: 35
  start-page: 3377
  year: 2014
  end-page: 3385
  article-title: Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
  publication-title: Eur Heart J
– volume: 67
  start-page: 2888
  year: 2016
  end-page: 2899
  article-title: Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF
  publication-title: J Am Coll Cardiol
– volume: 9
  start-page: 2168
  year: 2011
  end-page: 2175
  article-title: Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial
  publication-title: J Thromb Haemost
– volume: 139
  start-page: 173
  year: 2010
  end-page: 180
  article-title: Atrial fibrillation prevalence, incidence and risk of stroke and all‐cause death among Chinese
  publication-title: Int J Cardiol
– volume: 66
  start-page: 677
  year: 2015
  end-page: 688
  article-title: Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation
  publication-title: Am J Kidney Dis
– volume: 62
  start-page: 1187
  year: 2013
  end-page: 1192
  article-title: Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study
  publication-title: J Am Coll Cardiol
– volume: 123
  start-page: 1098
  year: 2011
  end-page: 1107
  article-title: Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies
  publication-title: Circulation
– volume: 373
  start-page: 823
  year: 2015
  end-page: 833
  article-title: Perioperative bridging anticoagulation in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 104
  start-page: 418
  year: 2015
  end-page: 429
  article-title: Renal function and non‐vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta‐regression analysis
  publication-title: Clin Res Cardiol
– volume: 83
  start-page: 14
  year: 2016
  end-page: 21
  article-title: Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy
  publication-title: Biomed Pharmacother
– volume: 78
  start-page: 877
  year: 2014
  end-page: 885
  article-title: Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
  publication-title: Br J Clin Pharmacol
– volume: 79
  start-page: 432
  year: 2015
  end-page: 438
  article-title: Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy‐pooled analysis of the shinken database, J‐RHYTHM registry, and Fushimi AF registry
  publication-title: Circ J
– volume: 159
  start-page: 1102
  year: 2010
  end-page: 1107
  article-title: Chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC)
  publication-title: Am Heart J
– volume: 64
  start-page: 2471
  year: 2014
  end-page: 2482
  article-title: Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study
  publication-title: J Am Coll Cardiol
– volume: 4
  start-page: 1
  year: 2003
  article-title: Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality
  publication-title: BMC Nephrol
– volume: 136
  start-page: 1019
  year: 2008
  end-page: 1027
  article-title: A novel device for left atrial appendage exclusion: the third‐generation atrial exclusion device
  publication-title: J Thorac Cardiovasc Surg
– volume: 20
  start-page: 2223
  year: 2009
  end-page: 2233
  article-title: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation
  publication-title: J Am Soc Nephrol
– volume: 6
  start-page: 460
  year: 2013
  end-page: 466
  article-title: Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol
– volume: 3
  start-page: 45
  year: 2014
  end-page: 54
  article-title: Rationale and design of the left atrial appendage occlusion study (LAAOS) III
  publication-title: Ann Cardiothorac Surg
– volume: 133
  start-page: 782
  year: 2014
  end-page: 789
  article-title: Cost‐effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation in Taiwan
  publication-title: Thromb Res
– volume: 129
  start-page: 1850
  year: 2014
  end-page: 1859
  article-title: Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
  publication-title: Circulation
– volume: 123
  start-page: 131
  year: 2011
  end-page: 136
  article-title: Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion
  publication-title: Circulation
– volume: 58
  start-page: 395
  year: 2011
  end-page: 401
  article-title: A new risk scheme to predict warfarin‐associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study
  publication-title: J Am Coll Cardiol
– volume: 375
  start-page: 1131
  year: 2016
  end-page: 1141
  article-title: Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
  publication-title: N Engl J Med
– volume: 129
  start-page: 1196
  year: 2014
  end-page: 1203
  article-title: Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis
  publication-title: Circulation
– volume: 80
  start-page: 860
  year: 2016
  end-page: 869
  article-title: Edoxaban vs. warfarin in East Asian patients with atrial fibrillation‐an ENGAGE AF‐TIMI 48 subanalysis
  publication-title: Circ J
– volume: 47
  start-page: 2462
  year: 2016
  end-page: 2469
  article-title: Validation of a Modified CHA2DS2‐VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study
  publication-title: Stroke
– volume: 2
  start-page: e000067
  year: 2013
  article-title: Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
  publication-title: J Am Heart Assoc
– volume: 188
  start-page: 361
  year: 2016
  end-page: 362
  article-title: Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation
  publication-title: CMAJ
– volume: 17
  start-page: 1467
  year: 2015
  end-page: 1507
  article-title: Updated European Heart Rhythm Association practical guide on the use of non‐vitamin K antagonist anticoagulants in patients with non‐valvular atrial fibrillation
  publication-title: Europace
– volume: 311
  start-page: 919
  year: 2014
  end-page: 928
  article-title: Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation
  publication-title: JAMA
– volume: 369
  start-page: 2093
  year: 2013
  end-page: 2104
  article-title: Edoxaban versus warfarin in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 132
  start-page: 167
  year: 2015
  end-page: 173
  article-title: Perioperative management of dabigatran: a prospective cohort study
  publication-title: Circulation
– volume: 10
  start-page: 306
  year: 2010
  end-page: 311
  article-title: Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?
  publication-title: Interact Cardiovasc Thorac Surg
– volume: 79
  start-page: 838
  year: 2015
  end-page: 846
  article-title: Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
  publication-title: Br J Clin Pharmacol
– volume: 7
  start-page: 1333
  year: 2014
  end-page: 1351
  article-title: Direct oral anticoagulants: new drugs and new concepts
  publication-title: JACC: Cardiovasc Interv
– volume: 54
  start-page: 2032
  year: 2009
  end-page: 2039
  article-title: Role of the CHADS2Score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation
  publication-title: J Am Coll Cardiol
– volume: 11
  start-page: 127
  year: 1995
  end-page: 130
  article-title: Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD
  publication-title: Adv Perit Dial
– volume: 107
  start-page: 1172
  year: 2012
  end-page: 1179
  article-title: The value of the CHA2DS2‐VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0‐1: a nationwide cohort study
  publication-title: Thromb Haemost
– volume: 76
  start-page: 2104
  year: 2012
  end-page: 2111
  article-title: Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation‐the J‐ROCKET AF study
  publication-title: Circ J
– volume: 120
  start-page: 1927
  year: 2009
  end-page: 1932
  article-title: Left atrial appendage occlusion does not eliminate the need for warfarin
  publication-title: Circulation
– volume: 36
  start-page: 1805
  year: 2015
  end-page: 1811
  article-title: Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non‐valvular atrial fibrillation
  publication-title: Eur Heart J
– volume: 149
  start-page: 401
  year: 2016
  end-page: 412
  article-title: Clinical characteristics and outcomes in extreme elderly (Age ≥ 85 Years) Japanese patients with atrial fibrillation: the Fushimi AF registry
  publication-title: Chest
– volume: 365
  start-page: 981
  year: 2011
  end-page: 992
  article-title: Apixaban versus warfarin in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 135
  start-page: 334
  year: 2017
  end-page: 337
  article-title: PIONEERs! the beginning of the end of full‐dose triple therapy with warfarin?
  publication-title: Circulation
– volume: 311
  start-page: 913
  year: 2014
  end-page: 915
  article-title: Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission?
  publication-title: JAMA
– volume: 116
  start-page: 2531
  year: 2007
  end-page: 2534
  article-title: Atrial fibrillation ablation in patients with therapeutic international normalized ratio
  publication-title: Comp Strateg Anticoagulation Manag Periprocedural Period Circ
– volume: 22
  start-page: 983
  year: 1991
  end-page: 988
  article-title: Atrial fibrillation as an independent risk factor for stroke: the Framingham study
  publication-title: Stroke
– volume: 60
  start-page: 861
  year: 2012
  end-page: 867
  article-title: Performance of the HEMORR2HAGES, ATRIA, and HAS‐BLED bleeding risk–prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (Evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) Study
  publication-title: J Am Coll Cardiol
– volume: 50
  start-page: 309
  year: 2007
  end-page: 315
  article-title: Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
  publication-title: J Am Coll Cardiol
– volume: 64
  start-page: 1658
  year: 2014
  end-page: 1665
  article-title: Using the CHA2DS2‐VASc score for refining stroke risk stratification in ׳low‐risk׳ Asian patients with atrial fibrillation
  publication-title: J Am Coll Cardiol
– volume: 33
  start-page: 2821
  year: 2012
  end-page: 2830
  article-title: Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
  publication-title: Eur Heart J
– volume: 141
  start-page: e326S
  year: 2012
  end-page: e3250
  article-title: Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence‐based clinical practice guidelines
  publication-title: Chest
– volume: 5
  start-page: 302
  year: 2012
  end-page: 311
  article-title: Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta‐analysis
  publication-title: Circ Arrhythm Electrophysiol
– volume: 30
  start-page: 888
  year: 2014
  end-page: 897
  article-title: Novel oral anticoagulants in patients with renal insufficiency: a meta‐analysis of randomized trials
  publication-title: Can J Cardiol
– volume: 127
  start-page: 720
  year: 2013
  end-page: 729
  article-title: Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3‐year Follow‐up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial
  publication-title: Circulation
– volume: 54
  start-page: 2227
  year: 2015
  end-page: 2239
  article-title: Mechanism of drug–drug interactions mediated by human cytochrome P450 CYP3A4 monomer
  publication-title: Biochemistry
– volume: 129
  start-page: 961
  year: 2014
  end-page: 970
  article-title: Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE‐LY (Randomized evaluation of long‐term anticoagulation therapy) trial analysis
  publication-title: Circulation
– volume: 39
  start-page: 1436
  year: 2002
  end-page: 1442
  article-title: Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct‐current cardioversion: final results of the Ludwigshafen observational cardioversion study
  publication-title: J Am Coll Cardiol
– volume: 44
  start-page: 1226
  year: 2013
  end-page: 1231
  article-title: Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes
  publication-title: Stroke
– volume: 364
  start-page: 806
  year: 2011
  end-page: 817
  article-title: Apixaban in patients with atrial fibrillation
  publication-title: N Engl J Med
– volume: 202
  start-page: 578
  year: 2016
  end-page: 585
  article-title: Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: review of the literature and recommendations for specific populations and procedures
  publication-title: Int J Cardiol
– volume: 49
  start-page: 278
  year: 2015
  end-page: 284
  article-title: Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation
  publication-title: Ann Pharmacother
– volume: 168
  start-page: 515
  year: 2013
  end-page: 522
  article-title: Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?
  publication-title: Int J Cardiol
– volume: 35
  start-page: 1844
  year: 2014
  end-page: 1855
  article-title: Edoxaban: a focused review of its clinical pharmacology
  publication-title: Eur Heart J
– volume: 383
  start-page: 955
  year: 2014
  end-page: 962
  article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta‐analysis of randomised trials
  publication-title: Lancet
– volume: 4
  start-page: 14
  year: 2011
  end-page: 21
  article-title: Moving the tipping point
  publication-title: Circ Cardiovasc Qual Outcomes
– volume: 75
  start-page: 1053
  year: 2013
  end-page: 1062
  article-title: Oral bioavailability of dabigatran etexilate (Pradaxa®) after co‐medication with verapamil in healthy subjects
  publication-title: Br J Clin Pharmacol
– volume: 142
  start-page: 1002
  year: 2011
  end-page: 1009
  article-title: Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial
  publication-title: J Thorac Cardiovasc Surg
– volume: 5
  start-page: 173
  year: 2010
  end-page: 181
  article-title: Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease
  publication-title: Clin J Am Soci Nephrol
– volume: 59
  start-page: 1168
  year: 2012
  end-page: 1174
  article-title: Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry
  publication-title: J Am Coll Cardiol
– volume: 109
  start-page: 378
  year: 2012
  end-page: 382
  article-title: Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF‐Asia Pacific [AP]) registry
  publication-title: Am J Cardiol
– volume: 134
  start-page: 589
  year: 2016
  end-page: 598
  article-title: Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE‐LY trial (randomized evaluation of long‐term anticoagulant therapy)
  publication-title: Circulation
– volume: 10
  start-page: 261
  year: 2012
  end-page: 267
  article-title: Predictors of major bleeding in peri‐procedural anticoagulation management
  publication-title: J Thromb Haemost
– ident: e_1_2_13_137_2
  doi: 10.1016/j.jacc.2008.03.067
– ident: e_1_2_13_255_2
  doi: 10.1161/CIRCEP.113.000320
– ident: e_1_2_13_90_2
  doi: 10.1161/CIRCULATIONAHA.113.004777
– ident: e_1_2_13_273_2
  doi: 10.1182/blood-2012-11-468207
– ident: e_1_2_13_194_2
  doi: 10.1007/s00392-014-0797-9
– ident: e_1_2_13_14_2
  doi: 10.1253/circj.CJ-14-1245
– ident: e_1_2_13_210_2
  doi: 10.1161/CIRCULATIONAHA.115.019794
– ident: e_1_2_13_105_2
  doi: 10.1016/j.jacc.2016.12.038
– ident: e_1_2_13_52_2
  doi: 10.1038/srep24376
– ident: e_1_2_13_254_2
  doi: 10.1016/j.hrthm.2012.12.011
– ident: e_1_2_13_253_2
  doi: 10.1161/CIRCEP.111.964916
– ident: e_1_2_13_56_2
  doi: 10.1016/j.hrthm.2014.04.021
– ident: e_1_2_13_239_2
  doi: 10.1016/S0735-1097(02)02052-1
– ident: e_1_2_13_141_2
  doi: 10.1016/j.jtcvs.2008.06.002
– ident: e_1_2_13_271_2
  doi: 10.1161/CIRCULATIONAHA.114.014343
– ident: e_1_2_13_74_2
  doi: 10.1161/01.STR.21.2.230
– ident: e_1_2_13_108_2
  doi: 10.1378/chest.13-0054
– ident: e_1_2_13_94_2
  doi: 10.1016/0049-3848(95)00162-K
– ident: e_1_2_13_15_2
  doi: 10.1253/circj.CJ-14-1131
– ident: e_1_2_13_129_2
  doi: 10.1016/j.jacc.2013.03.035
– ident: e_1_2_13_195_2
  doi: 10.1016/j.jacc.2016.02.082
– ident: e_1_2_13_13_2
  doi: 10.1016/j.jacc.2016.06.057
– ident: e_1_2_13_79_2
  doi: 10.1161/CIRCULATIONAHA.111.020982
– ident: e_1_2_13_95_2
  doi: 10.1159/000186153
– ident: e_1_2_13_262_2
  doi: 10.1016/j.jacc.2009.07.037
– ident: e_1_2_13_5_2
  doi: 10.1161/STROKEAHA.116.013378
– ident: e_1_2_13_226_2
  doi: 10.1016/j.jstrokecerebrovasdis.2016.04.006
– ident: e_1_2_13_263_2
  doi: 10.1111/j.1540-8167.2009.01540.x
– ident: e_1_2_13_227_2
  doi: 10.1161/CIRCULATIONAHA.111.090464
– ident: e_1_2_13_145_2
  doi: 10.1007/s40264-016-0443-8
– ident: e_1_2_13_269_2
  doi: 10.1016/j.jacc.2011.12.014
– ident: e_1_2_13_40_2
  doi: 10.1016/j.jfma.2016.10.005
– year: 2014
  ident: e_1_2_13_120_2
  article-title: Edoxaban versus warfarin in East‐Asian (Including Japanese) patients with atrial fibrillation―an ENGAGE AF‐TIMI 48 Sub‐analysis
  publication-title: Circ J
– ident: e_1_2_13_206_2
  doi: 10.1161/STROKEAHA.113.004506
– ident: e_1_2_13_114_2
  doi: 10.1093/europace/euv309
– ident: e_1_2_13_124_2
  doi: 10.1016/0003-4975(95)00887-X
– ident: e_1_2_13_162_2
  doi: 10.1177/0091270005274550
– ident: e_1_2_13_89_2
  doi: 10.1161/CIRCULATIONAHA.110.964171
– ident: e_1_2_13_172_2
  doi: 10.1159/000180580
– ident: e_1_2_13_221_2
  doi: 10.1111/j.1538-7836.2012.04630.x
– ident: e_1_2_13_30_2
  doi: 10.1136/bmj.d124
– ident: e_1_2_13_192_2
  doi: 10.1161/CIRCULATIONAHA.116.022361
– ident: e_1_2_13_197_2
  doi: 10.1056/NEJMoa1611594
– ident: e_1_2_13_268_2
  doi: 10.1093/eurheartj/ehu421
– ident: e_1_2_13_60_2
  doi: 10.1056/NEJMoa1007432
– ident: e_1_2_13_83_2
  doi: 10.1186/1471-2369-4-1
– ident: e_1_2_13_126_2
  doi: 10.4244/EIJV6I2A35
– ident: e_1_2_13_12_2
  doi: 10.1161/CIRCULATIONAHA.112.107128
– ident: e_1_2_13_97_2
  doi: 10.1093/eurheartj/ehu139
– ident: e_1_2_13_185_2
  doi: 10.1053/j.ajkd.2015.05.019
– ident: e_1_2_13_43_2
  doi: 10.1161/STROKEAHA.116.013880
– ident: e_1_2_13_117_2
  doi: 10.1016/j.jacc.2012.02.008
– ident: e_1_2_13_28_2
  doi: 10.1016/j.jacc.2007.01.098
– ident: e_1_2_13_4_2
  doi: 10.1016/j.jstrokecerebrovasdis.2015.07.016
– ident: e_1_2_13_229_2
  doi: 10.1182/blood-2014-08-595496
– ident: e_1_2_13_76_2
  doi: 10.1016/S0140-6736(10)61194-4
– ident: e_1_2_13_44_2
  doi: 10.1016/j.ahj.2005.04.017
– volume: 125
  start-page: 666
  year: 2015
  ident: e_1_2_13_211_2
  article-title: Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials
  publication-title: Pol Arch Med Wewn
  doi: 10.20452/pamw.3049
– ident: e_1_2_13_242_2
  doi: 10.1016/j.jacc.2013.02.025
– ident: e_1_2_13_156_2
  doi: 10.1111/bcp.12055
– ident: e_1_2_13_228_2
  doi: 10.1161/CIRCULATIONAHA.113.005754
– ident: e_1_2_13_50_2
  doi: 10.1093/eurheartj/ehr488
– ident: e_1_2_13_168_2
  doi: 10.5301/jn.5000010
– ident: e_1_2_13_189_2
  doi: 10.1161/CIRCULATIONAHA.113.003628
– ident: e_1_2_13_54_2
  doi: 10.1016/j.thromres.2011.11.005
– ident: e_1_2_13_251_2
  doi: 10.1093/europace/euv190
– ident: e_1_2_13_136_2
  doi: 10.1510/icvts.2009.227991
– volume: 121
  start-page: 2550
  year: 2010
  ident: e_1_2_13_252_2
  article-title: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation
  publication-title: Impact Periprocedural Ther Int Norm Ratio Circ
– ident: e_1_2_13_109_2
  doi: 10.1016/S0140-6736(13)62376-4
– ident: e_1_2_13_257_2
  doi: 10.1111/j.1540-8159.2009.02429.x
– ident: e_1_2_13_84_2
  doi: 10.1681/ASN.2009030319
– ident: e_1_2_13_112_2
  doi: 10.1160/TH14-03-0228
– ident: e_1_2_13_8_2
  doi: 10.1160/TH13-11-0948
– ident: e_1_2_13_77_2
  doi: 10.1161/JAHA.112.000067
– ident: e_1_2_13_167_2
  doi: 10.1016/j.amjcard.2009.07.026
– ident: e_1_2_13_216_2
  doi: 10.1111/j.1538-7836.2011.04572.x
– ident: e_1_2_13_35_2
  doi: 10.1016/j.hrthm.2015.08.017
– ident: e_1_2_13_127_2
  doi: 10.1016/S0140-6736(09)61343-X
– ident: e_1_2_13_219_2
  doi: 10.1007/s00228-005-0043-5
– ident: e_1_2_13_247_2
  doi: 10.1016/S0002-9343(01)00716-1
– ident: e_1_2_13_2_2
  doi: 10.1016/S0140-6736(16)31257-0
– ident: e_1_2_13_48_2
  doi: 10.1016/S0140-6736(16)00741-8
– ident: e_1_2_13_131_2
  doi: 10.1161/CIRCULATIONAHA.112.114389
– ident: e_1_2_13_178_2
  doi: 10.1159/000046216
– ident: e_1_2_13_146_2
  doi: 10.1016/j.biopha.2016.06.012
– ident: e_1_2_13_92_2
  doi: 10.1016/S0272-6386(12)80248-4
– ident: e_1_2_13_104_2
  doi: 10.1161/CIRCULATIONAHA.116.026714
– ident: e_1_2_13_34_2
  doi: 10.1161/CIR.0000000000000040
– ident: e_1_2_13_88_2
  doi: 10.1038/ki.2009.477
– ident: e_1_2_13_265_2
  doi: 10.1161/CIRCEP.113.000515
– ident: e_1_2_13_118_2
  doi: 10.1253/circj.CJ-15-0574
– ident: e_1_2_13_148_2
  doi: 10.1080/17425255.2016.1225037
– ident: e_1_2_13_275_2
  doi: 10.1056/NEJMoa1510991
– ident: e_1_2_13_153_2
  doi: 10.1111/j.1538-7836.2011.04498.x
– ident: e_1_2_13_181_2
  doi: 10.1016/j.amjcard.2014.05.048
– ident: e_1_2_13_207_2
  doi: 10.1016/S1474-4422(07)70274-0
– ident: e_1_2_13_193_2
  doi: 10.1016/j.cjca.2014.04.015
– ident: e_1_2_13_240_2
  doi: 10.1016/S0735-1097(02)01785-0
– ident: e_1_2_13_38_2
  doi: 10.1161/CIRCOUTCOMES.110.958108
– ident: e_1_2_13_80_2
  doi: 10.2215/CJN.03170509
– ident: e_1_2_13_169_2
  doi: 10.1038/ki.2014.393
– ident: e_1_2_13_274_2
  doi: 10.1038/nm.3102
– ident: e_1_2_13_98_2
  doi: 10.1093/europace/euv289
– ident: e_1_2_13_261_2
  doi: 10.1007/s00392-009-0091-4
– ident: e_1_2_13_21_2
  doi: 10.1056/NEJMoa1009638
– ident: e_1_2_13_248_2
  doi: 10.1016/j.amjmed.2005.06.029
– ident: e_1_2_13_68_2
  doi: 10.1253/circj.CJ-14-0720
– ident: e_1_2_13_29_2
  doi: 10.1001/jama.285.22.2864
– ident: e_1_2_13_101_2
  doi: 10.1161/CIRCULATIONAHA.114.014807
– ident: e_1_2_13_264_2
  doi: 10.1177/1060028014563950
– ident: e_1_2_13_173_2
  doi: 10.1056/NEJMoa1105594
– ident: e_1_2_13_24_2
  doi: 10.1161/STROKEAHA.113.000990
– ident: e_1_2_13_180_2
  doi: 10.1016/j.jacc.2014.09.051
– ident: e_1_2_13_20_2
  doi: 10.1056/NEJMoa0905561
– ident: e_1_2_13_164_2
  doi: 10.1016/j.jacc.2012.09.057
– ident: e_1_2_13_9_2
  doi: 10.1161/01.STR.22.8.983
– ident: e_1_2_13_6_2
  doi: 10.1378/chest.15-1095
– volume: 19
  start-page: 1
  year: 2012
  ident: e_1_2_13_18_2
  article-title: The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia
  publication-title: Malays J Med Sci
– ident: e_1_2_13_45_2
  doi: 10.1378/chest.10-0134
– ident: e_1_2_13_110_2
  doi: 10.1371/journal.pone.0150674
– ident: e_1_2_13_59_2
  doi: 10.1016/j.ijcard.2014.11.182
– ident: e_1_2_13_191_2
  doi: 10.1093/eurheartj/ehr342
– ident: e_1_2_13_70_2
  doi: 10.1016/j.clinthera.2008.09.010
– ident: e_1_2_13_132_2
  doi: 10.1001/jama.2014.15192
– ident: e_1_2_13_159_2
  doi: 10.1111/bcp.12393
– ident: e_1_2_13_277_2
  doi: 10.1160/TH14-11-0982
– ident: e_1_2_13_214_2
  doi: 10.1111/jth.13305
– ident: e_1_2_13_151_2
  doi: 10.1111/bcp.12075
– ident: e_1_2_13_116_2
  doi: 10.1093/eurheartj/ehu181
– ident: e_1_2_13_163_2
  doi: 10.1016/j.clinthera.2016.05.004
– ident: e_1_2_13_42_2
  doi: 10.1016/j.cjca.2016.05.009
– ident: e_1_2_13_249_2
  doi: 10.1067/mhj.2000.106648
– ident: e_1_2_13_37_2
  doi: 10.1016/j.jacc.2014.11.046
– ident: e_1_2_13_165_2
  doi: 10.1016/j.jacc.2014.06.008
– ident: e_1_2_13_99_2
  doi: 10.1016/j.jacc.2015.03.601
– ident: e_1_2_13_123_2
  doi: 10.1160/TH13-09-0734
– ident: e_1_2_13_128_2
  doi: 10.1002/ccd.22764
– ident: e_1_2_13_7_2
  doi: 10.1161/STROKEAHA.113.675140
– ident: e_1_2_13_237_2
  doi: 10.4065/77.9.897
– ident: e_1_2_13_62_2
  doi: 10.1016/j.acvd.2014.01.001
– ident: e_1_2_13_58_2
  doi: 10.1253/circj.CJ-14-1042
– ident: e_1_2_13_64_2
  doi: 10.1016/j.thromres.2014.02.024
– ident: e_1_2_13_23_2
  doi: 10.1056/NEJMoa1310907
– ident: e_1_2_13_183_2
  doi: 10.1681/ASN.2009030319
– ident: e_1_2_13_190_2
  doi: 10.1093/eurheartj/ehs274
– ident: e_1_2_13_260_2
  doi: 10.1016/j.hrthm.2011.12.016
– ident: e_1_2_13_147_2
  doi: 10.1016/j.jcin.2014.06.014
– ident: e_1_2_13_51_2
  doi: 10.1016/j.jacc.2012.06.019
– ident: e_1_2_13_217_2
  doi: 10.1378/chest.11-2298
– ident: e_1_2_13_25_2
  doi: 10.1161/STROKEAHA.113.002968
– ident: e_1_2_13_223_2
  doi: 10.1182/blood-2012-06-415943
– ident: e_1_2_13_233_2
  doi: 10.1136/bmj.h2391
– volume: 36
  start-page: 3258
  year: 2015
  ident: e_1_2_13_47_2
  article-title: The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
  publication-title: Eur Heart J
– ident: e_1_2_13_100_2
  doi: 10.1161/CIRCULATIONAHA.115.020950
– ident: e_1_2_13_154_2
  doi: 10.1111/j.1365-2125.2012.04453.x
– ident: e_1_2_13_65_2
  doi: 10.1093/europace/euw073
– ident: e_1_2_13_135_2
  doi: 10.1136/heartjnl-2014-306332
– ident: e_1_2_13_235_2
  doi: 10.1093/europace/eut083
– ident: e_1_2_13_272_2
  doi: 10.1016/j.amjcard.2005.08.062
– ident: e_1_2_13_55_2
  doi: 10.1161/01.STR.0000198839.61112.ee
– ident: e_1_2_13_150_2
  doi: 10.1007/s00059-014-4188-9
– ident: e_1_2_13_17_2
  doi: 10.1016/j.jacc.2014.06.1203
– ident: e_1_2_13_41_2
  doi: 10.1016/j.jacc.2015.07.026
– ident: e_1_2_13_266_2
  doi: 10.1016/j.hrthm.2014.03.003
– ident: e_1_2_13_103_2
  doi: 10.1016/j.jacc.2016.12.031
– ident: e_1_2_13_201_2
  doi: 10.1016/S1474-4422(10)70274-X
– ident: e_1_2_13_270_2
  doi: 10.1056/NEJMoa1311376
– ident: e_1_2_13_236_2
  doi: 10.1016/j.jacc.2013.04.089
– ident: e_1_2_13_196_2
  doi: 10.1093/eurheartj/ehu298
– ident: e_1_2_13_224_2
  doi: 10.1503/cmaj.150867
– ident: e_1_2_13_205_2
  doi: 10.1161/STROKEAHA.112.650614
– ident: e_1_2_13_66_2
  doi: 10.1016/j.hrthm.2016.03.049
– ident: e_1_2_13_209_2
  doi: 10.1001/jama.2015.0846
– ident: e_1_2_13_49_2
  doi: 10.1111/jth.13386
– ident: e_1_2_13_186_2
  doi: 10.1016/j.cjca.2015.06.005
– ident: e_1_2_13_134_2
  doi: 10.1002/ccd.24872
– ident: e_1_2_13_176_2
  doi: 10.1016/j.jacc.2013.02.035
– ident: e_1_2_13_179_2
  doi: 10.1161/CIRCULATIONAHA.115.018294
– ident: e_1_2_13_121_2
  doi: 10.1253/circj.CJ-12-0454
– ident: e_1_2_13_203_2
  doi: 10.1016/S1474-4422(12)70092-3
– ident: e_1_2_13_155_2
  doi: 10.1111/bcp.12541
– ident: e_1_2_13_232_2
  doi: 10.1056/NEJMoa1502000
– ident: e_1_2_13_218_2
  doi: 10.1111/imj.12448
– ident: e_1_2_13_213_2
  doi: 10.1016/j.ijcard.2015.09.035
– ident: e_1_2_13_225_2
  doi: 10.1056/NEJMoa1501035
– ident: e_1_2_13_32_2
  doi: 10.1161/CIRCEP.111.966713
– ident: e_1_2_13_144_2
  doi: 10.1016/j.beha.2013.07.009
– ident: e_1_2_13_208_2
  doi: 10.1161/CIRCULATIONAHA.115.015735
– ident: e_1_2_13_53_2
  doi: 10.1016/j.amjmed.2015.10.001
– ident: e_1_2_13_157_2
  doi: 10.1503/cmaj.150580
– ident: e_1_2_13_87_2
  doi: 10.1159/000180784
– ident: e_1_2_13_16_2
  doi: 10.1161/STROKEAHA.114.006476
– ident: e_1_2_13_142_2
  doi: 10.1016/j.jtcvs.2011.07.052
– ident: e_1_2_13_200_2
  doi: 10.1212/01.wnl.0000267275.68538.8d
– ident: e_1_2_13_69_2
  doi: 10.7326/0003-4819-146-12-200706190-00007
– ident: e_1_2_13_115_2
  doi: 10.2165/0003088-200948010-00001
– ident: e_1_2_13_36_2
  doi: 10.1160/TH12-03-0175
– ident: e_1_2_13_106_2
  doi: 10.1056/NEJMoa1300615
– ident: e_1_2_13_27_2
  doi: 10.1016/j.ahj.2014.06.005
– ident: e_1_2_13_199_2
  doi: 10.1001/archinte.1994.00420130036007
– ident: e_1_2_13_149_2
  doi: 10.1124/jpet.111.180240
– ident: e_1_2_13_246_2
  doi: 10.1056/NEJM200105103441901
– ident: e_1_2_13_143_2
  doi: 10.1001/archinte.165.10.1095
– ident: e_1_2_13_133_2
  doi: 10.1016/j.jacc.2014.04.029
– ident: e_1_2_13_175_2
  doi: 10.1161/CIRCULATIONAHA.112.147512
– ident: e_1_2_13_259_2
  doi: 10.1056/NEJMoa1701005
– ident: e_1_2_13_67_2
  doi: 10.1161/CIRCULATIONAHA.113.005451
– ident: e_1_2_13_10_2
  doi: 10.1016/j.ijcard.2008.10.045
– ident: e_1_2_13_222_2
  doi: 10.1177/1076029609343004
– ident: e_1_2_13_72_2
  doi: 10.1111/cns.12021
– ident: e_1_2_13_46_2
  doi: 10.1016/j.jacc.2011.03.031
– ident: e_1_2_13_39_2
  doi: 10.1093/europace/euw295
– ident: e_1_2_13_107_2
  doi: 10.1161/JAHA.115.002322
– ident: e_1_2_13_57_2
  doi: 10.1016/j.jacc.2015.05.044
– ident: e_1_2_13_230_2
  doi: 10.1161/CIRCULATIONAHA.115.015688
– ident: e_1_2_13_204_2
  doi: 10.1161/STROKEAHA.116.013540
– ident: e_1_2_13_71_2
  doi: 10.1161/CIRCEP.113.000858
– ident: e_1_2_13_177_2
  doi: 10.1093/ndt/gfm051
– ident: e_1_2_13_188_2
  doi: 10.1378/chest.15-1719
– ident: e_1_2_13_113_2
  doi: 10.1016/S0140-6736(13)62343-0
– ident: e_1_2_13_78_2
  doi: 10.1161/CIRCEP.110.957100
– ident: e_1_2_13_119_2
  doi: 10.1161/STROKEAHA.115.009947
– ident: e_1_2_13_130_2
  doi: 10.1016/j.jacc.2012.06.046
– volume: 116
  start-page: 2531
  year: 2007
  ident: e_1_2_13_256_2
  article-title: Atrial fibrillation ablation in patients with therapeutic international normalized ratio
  publication-title: Comp Strateg Anticoagulation Manag Periprocedural Period Circ
– ident: e_1_2_13_26_2
  doi: 10.1253/circj.CJ-15-1082
– ident: e_1_2_13_166_2
  doi: 10.1111/bcp.12391
– ident: e_1_2_13_125_2
  doi: 10.1161/CIRCULATIONAHA.108.844779
– ident: e_1_2_13_245_2
  doi: 10.1016/S0140-6736(16)31474-X
– ident: e_1_2_13_111_2
  doi: 10.1016/j.jstrokecerebrovasdis.2016.08.030
– ident: e_1_2_13_276_2
  doi: 10.1056/NEJMoa1607887
– ident: e_1_2_13_212_2
  doi: 10.1097/MJT.0000000000000121
– ident: e_1_2_13_85_2
  doi: 10.2215/CJN.04550511
– ident: e_1_2_13_170_2
  doi: 10.1001/jama.2014.1781
– ident: e_1_2_13_231_2
  doi: 10.1093/eurheartj/eht557
– ident: e_1_2_13_138_2
  doi: 10.1016/j.ahj.2004.09.054
– volume: 3
  start-page: 45
  year: 2014
  ident: e_1_2_13_139_2
  article-title: Rationale and design of the left atrial appendage occlusion study (LAAOS) III
  publication-title: Ann Cardiothorac Surg
– ident: e_1_2_13_152_2
  doi: 10.1021/acs.biochem.5b00079
– ident: e_1_2_13_244_2
  doi: 10.1093/eurheartj/ehu367
– ident: e_1_2_13_215_2
  doi: 10.1016/j.jclinane.2016.06.016
– ident: e_1_2_13_11_2
  doi: 10.1378/chest.09-1584
– ident: e_1_2_13_187_2
  doi: 10.1016/j.cjca.2014.06.006
– ident: e_1_2_13_3_2
  doi: 10.1161/STROKEAHA.108.516344
– ident: e_1_2_13_81_2
  doi: 10.1016/j.ahj.2010.03.027
– ident: e_1_2_13_267_2
  doi: 10.1046/j.1540-8167.2004.03401.x
– ident: e_1_2_13_234_2
  doi: 10.1161/ATVBAHA.114.303402
– ident: e_1_2_13_61_2
  doi: 10.1016/j.ijcard.2012.09.187
– ident: e_1_2_13_238_2
  doi: 10.1016/S0002-9149(98)00704-8
– ident: e_1_2_13_202_2
  doi: 10.1016/S1474-4422(12)70042-X
– ident: e_1_2_13_241_2
  doi: 10.1161/CIRCULATIONAHA.110.977546
– ident: e_1_2_13_182_2
  doi: 10.1001/jama.2014.1334
– ident: e_1_2_13_161_2
  doi: 10.1097/FJC.0b013e3182970991
– ident: e_1_2_13_174_2
  doi: 10.1093/eurheartj/eht328
– ident: e_1_2_13_22_2
  doi: 10.1056/NEJMoa1107039
– ident: e_1_2_13_160_2
  doi: 10.1111/j.1365-2125.2006.02776.x
– ident: e_1_2_13_250_2
  doi: 10.7326/0003-4819-126-8-199704150-00005
– ident: e_1_2_13_63_2
  doi: 10.1016/j.amjcard.2011.08.046
– ident: e_1_2_13_102_2
  doi: 10.1093/eurheartj/ehu305
– ident: e_1_2_13_75_2
  doi: 10.1159/000077341
– ident: e_1_2_13_220_2
  doi: 10.1097/ALN.0b013e318289bcba
– volume: 2012
  start-page: 2719
  issue: 33
  year: 2012
  ident: e_1_2_13_33_2
  article-title: focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the American College of Cardiology
  publication-title: Eur Heart J
– ident: e_1_2_13_82_2
  doi: 10.2215/CJN.02400311
– ident: e_1_2_13_198_2
  doi: 10.1161/CIRCULATIONAHA.116.025923
– ident: e_1_2_13_184_2
  doi: 10.1016/j.ijcard.2016.07.118
– ident: e_1_2_13_122_2
  doi: 10.1016/j.hrthm.2016.09.010
– ident: e_1_2_13_171_2
  doi: 10.1161/CIRCULATIONAHA.112.123992
– ident: e_1_2_13_73_2
  doi: 10.1161/01.STR.0000087149.42294.8C
– ident: e_1_2_13_158_2
  doi: 10.1007/s40261-015-0298-2
– ident: e_1_2_13_19_2
  doi: 10.1161/JAHA.113.000250
– ident: e_1_2_13_140_2
  doi: 10.1016/j.cjca.2013.06.015
– ident: e_1_2_13_86_2
  doi: 10.1053/j.ajkd.2007.06.017
– volume: 11
  start-page: 127
  year: 1995
  ident: e_1_2_13_96_2
  article-title: Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD
  publication-title: Adv Perit Dial
– ident: e_1_2_13_31_2
  doi: 10.1016/j.jacc.2011.08.045
– ident: e_1_2_13_93_2
  doi: 10.1093/ndt/13.8.2053
– ident: e_1_2_13_91_2
  doi: 10.1038/ki.2011.223
– ident: e_1_2_13_258_2
  doi: 10.1093/eurheartj/ehv177
– ident: e_1_2_13_243_2
  doi: 10.1016/j.jacc.2013.09.062
– reference: 26504109 - Europace. 2016 May;18(5):665-71
– reference: 22137743 - Thromb Res. 2012 Jul;130(1):21-6
– reference: 21873708 - Eur Heart J. 2011 Oct;32(19):2387-94
– reference: 16328318 - Eur J Clin Pharmacol. 2005 Dec;61(12):873-80
– reference: 22386883 - Heart Rhythm. 2012 Apr;9(4):632-696.e21
– reference: 26811362 - CMAJ. 2016 Jun 14;188(9):669-72
– reference: 11346805 - N Engl J Med. 2001 May 10;344(19):1411-20
– reference: 27523274 - Can J Cardiol. 2016 Dec;32(12 ):1381-1387
– reference: 27959713 - N Engl J Med. 2016 Dec 22;375(25):2423-2434
– reference: 24747420 - Heart Rhythm. 2014 Aug;11(8):1401-8
– reference: 24500243 - Thromb Haemost. 2014 May 5;111(5):789-97
– reference: 16443416 - Am J Med. 2006 Feb;119(2):142-6
– reference: 25573984 - Heart. 2015 Jun;101(11):877-83
– reference: 24054920 - Can J Cardiol. 2013 Nov;29(11):1443-7
– reference: 21903982 - Clin J Am Soc Nephrol. 2011 Nov;6(11):2599-604
– reference: 25832311 - Thromb Haemost. 2015 May;113(5):931-42
– reference: 25710659 - JAMA. 2015 Feb 24;313(8):824-36
– reference: 24315724 - Lancet. 2014 Mar 15;383(9921):955-62
– reference: 26304938 - J Am Heart Assoc. 2015 Aug 24;4(8):e002322
– reference: 21059484 - Lancet Neurol. 2010 Dec;9(12):1157-63
– reference: 24394381 - Eur Heart J. 2014 Jul 21;35(28):1888-96
– reference: 26696619 - CMAJ. 2016 Mar 15;188(5):361-2
– reference: 1866765 - Stroke. 1991 Aug;22(8):983-8
– reference: 24552831 - Circulation. 2014 May 6;129(18):1850-9
– reference: 21959598 - Clin J Am Soc Nephrol. 2011 Nov;6(11):2662-8
– reference: 27292282 - Clin Ther. 2016 Jul;38(7):1674-1685.e1
– reference: 25399274 - JAMA. 2014 Nov 19;312(19):1988-98
– reference: 24682348 - Circulation. 2014 Dec 2;130(23):2071-104
– reference: 24595776 - JAMA. 2014 Mar 5;311(9):919-28
– reference: 19932791 - Am J Cardiol. 2009 Dec 1;104(11):1551-5
– reference: 18757287 - Stroke. 2009 Jan;40(1):235-40
– reference: 25966905 - Circulation. 2015 Jul 21;132(3):167-73
– reference: 18840379 - Clin Ther. 2008 Sep;30(9):1726-36
– reference: 22932800 - Blood. 2012 Oct 11;120(15):2954-62
– reference: 19901203 - Circulation. 2009 Nov 10;120(19):1927-32; discussion 1932
– reference: 19046608 - Int J Cardiol. 2010 Mar 4;139(2):173-80
– reference: 12225717 - J Am Coll Cardiol. 2002 Sep 4;40(5):926-33
– reference: 25616425 - Herz. 2015 Apr;40 Suppl 2:140-5
– reference: 22894575 - N Engl J Med. 2012 Aug 16;367(7):625-35
– reference: 22118827 - Am J Cardiol. 2012 Feb 1;109(3):378-82
– reference: 11401607 - JAMA. 2001 Jun 13;285(22):2864-70
– reference: 23966309 - Eur Heart J. 2013 Dec;34(46):3572-9
– reference: 19071881 - Clin Pharmacokinet. 2009;48(1):1-22
– reference: 23953899 - Best Pract Res Clin Haematol. 2013 Jun;26(2):103-14
– reference: 8534685 - Adv Perit Dial. 1995;11:127-30
– reference: 26106009 - Circulation. 2015 Aug 25;132(8):624-32
– reference: 26378611 - Chest. 2016 Apr;149(4):951-9
– reference: 22319004 - Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26
– reference: 26059010 - Circulation. 2015 Aug 11;132(6):517-25
– reference: 25416564 - Clin Res Cardiol. 2015 May;104(5):418-29
– reference: 21750584 - Kidney Int. 2011 Sep;80(6):572-86
– reference: 23991661 - N Engl J Med. 2013 Sep 26;369(13):1206-14
– reference: 20801496 - Lancet. 2010 Sep 18;376(9745):975-83
– reference: 27358434 - Circulation. 2016 Jul 5;134(1):24-36
– reference: 26341732 - J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2613-8
– reference: 25064581 - Can J Cardiol. 2014 Aug;30(8):888-97
– reference: 21757117 - J Am Coll Cardiol. 2011 Jul 19;58(4):395-401
– reference: 25213003 - Circ J. 2014;78(10):2367-72
– reference: 22922413 - Eur Heart J. 2012 Nov;33(21):2719-47
– reference: 23743976 - Stroke. 2013 Jul;44(7):1891-6
– reference: 21646496 - Circulation. 2011 Jun 28;123(25):2946-53
– reference: 27671097 - J Stroke Cerebrovasc Dis. 2017 Jan;26(1):64-69
– reference: 25104528 - J Am Coll Cardiol. 2014 Aug 12;64(6):585-7
– reference: 26383720 - J Am Coll Cardiol. 2015 Sep 22;66(12):1339-47
– reference: 19762550 - Chest. 2010 Feb;137(2):263-72
– reference: 25501800 - Circ J. 2015;79(2):432-8
– reference: 25677422 - J Am Coll Cardiol. 2015 Feb 24;65(7):635-42
– reference: 16385088 - Stroke. 2006 Feb;37(2):447-51
– reference: 26482233 - Am J Med. 2016 Jun;129(6):600-7
– reference: 21972820 - J Thromb Haemost. 2011 Nov;9(11):2168-75
– reference: 17998456 - Circulation. 2007 Nov 27;116(22):2531-4
– reference: 12907817 - Stroke. 2003 Sep;34(9):2091-6
– reference: 12546711 - BMC Nephrol. 2003 Jan 24;4:1
– reference: 23455714 - Nat Med. 2013 Apr;19(4):446-51
– reference: 23275377 - Circulation. 2013 Feb 5;127(5):569-74
– reference: 11403753 - Am J Med. 2001 Jun 15;110(9):694-702
– reference: 27507860 - Stroke. 2016 Sep;47(9):2197-202
– reference: 24998121 - J Am Coll Cardiol. 2014 Jul 8;64(1):1-12
– reference: 23669885 - Chest. 2013 Nov;144(5):1555-1563
– reference: 25910800 - Circulation. 2015 Jun 23;131(25):2176-84
– reference: 22271713 - Circ Arrhythm Electrophysiol. 2012 Apr;5(2):302-11
– reference: 26361166 - J Am Coll Cardiol. 2015 Sep 15;66(11):1310-1
– reference: 20562072 - EuroIntervention. 2010 Jun;6(2):220-6
– reference: 26969761 - Circulation. 2016 Apr 19;133(16):1540-7
– reference: 24315725 - Lancet. 2014 Mar 15;383(9921):931-3
– reference: 26181726 - Chest. 2016 Feb;149(2):401-12
– reference: 25975659 - Eur Heart J. 2015 Jul 21;36(28):1805-11
– reference: 18954645 - J Thorac Cardiovasc Surg. 2008 Oct;136(4):1019-27
– reference: 24595773 - JAMA. 2014 Mar 5;311(9):913-5
– reference: 22473219 - Thromb Haemost. 2012 Jun;107(6):1172-9
– reference: 17100983 - Br J Clin Pharmacol. 2007 Apr;63(4):469-76
– reference: 26205604 - J Am Coll Cardiol. 2015 Jul 28;66(4):488-90
– reference: 24452752 - Circulation. 2014 Mar 18;129(11):1196-203
– reference: 15831779 - J Clin Pharmacol. 2005 May;45(5):555-63
– reference: 20007681 - Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81
– reference: 27625386 - Stroke. 2016 Oct;47(10 ):2462-9
– reference: 26214205 - Am J Ther. 2016 Mar-Apr;23 (2):e474-84
– reference: 23899712 - Circ Arrhythm Electrophysiol. 2013 Aug;6(4):e65
– reference: 22315266 - Chest. 2012 Feb;141(2 Suppl):e326S-e350S
– reference: 22115643 - J Am Coll Cardiol. 2011 Nov 29;58(23):2380-5
– reference: 21139092 - Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):14-21
– reference: 17679673 - Neurology. 2007 Aug 7;69(6):546-54
– reference: 22123000 - J Thromb Haemost. 2012 Feb;10(2):261-7
– reference: 25173541 - Am Heart J. 2014 Sep;168(3):303-9
– reference: 1244564 - Nephron. 1976;16(1):31-41
– reference: 23391196 - J Am Coll Cardiol. 2013 Feb 12;61(6):651-8
– reference: 21309657 - N Engl J Med. 2011 Mar 3;364(9):806-17
– reference: 28302287 - J Am Coll Cardiol. 2017 Mar 21;69(11):1363-1371
– reference: 19915883 - Clin Res Cardiol. 2010 Feb;99(2):125-8
– reference: 25500231 - J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82
– reference: 27535163 - Expert Opin Drug Metab Toxicol. 2016 Dec;12 (12 ):1445-1461
– reference: 26095746 - N Engl J Med. 2015 Aug 6;373(6):511-20
– reference: 26988871 - J Thromb Haemost. 2016 May;14(5):875-85
– reference: 23500298 - J Am Coll Cardiol. 2013 May 14;61(19):1998-2006
– reference: 24722803 - Eur Heart J. 2015 Feb 1;36(5):297-306
– reference: 24516797 - Ann Cardiothorac Surg. 2014 Jan;3(1):45-54
– reference: 22933567 - Eur Heart J. 2012 Nov;33(22):2821-30
– reference: 16086933 - Am Heart J. 2005 Aug;150(2):288-93
– reference: 19713308 - J Am Soc Nephrol. 2009 Oct;20(10):2223-33
– reference: 23615159 - J Cardiovasc Pharmacol. 2013 Aug;62(2):212-21
– reference: 24963566 - N Engl J Med. 2014 Jun 26;370(26):2467-77
– reference: 21200007 - Circulation. 2011 Jan 18;123(2):131-6
– reference: 20054291 - Kidney Int. 2010 Jun;77(12):1098-106
– reference: 23525418 - J Am Heart Assoc. 2013 Feb 19;2(1):e000067
– reference: 17395659 - Nephrol Dial Transplant. 2007 Jul;22(7):1910-5
– reference: 24763930 - Stroke. 2014 Jun;45(6):1739-47
– reference: 24556189 - Arch Cardiovasc Dis. 2014 Feb;107(2):77-87
– reference: 26680239 - Circulation. 2016 Jan 19;133(3):265-72
– reference: 22492518 - Stroke. 2012 Jun;43(6):1511-7
– reference: 19659617 - Pacing Clin Electrophysiol. 2009 Aug;32(8):995-9
– reference: 22180223 - J Nephrol. 2012 May-Jun;25(3):341-53
– reference: 27335063 - Europace. 2016 Sep;18(9):1308-18
– reference: 27659468 - J Am Coll Cardiol. 2016 Sep 27;68(13):1452-1464
– reference: 8572814 - Ann Thorac Surg. 1996 Feb;61(2):755-9
– reference: 1824735 - Am J Kidney Dis. 1991 Jan;17(1):38-42
– reference: 17720522 - Am J Kidney Dis. 2007 Sep;50(3):433-40
– reference: 2150218 - Nephron. 1990;56(3):271-6
– reference: 25515868 - Ann Pharmacother. 2015 Mar;49(3):278-84
– reference: 854139 - Nephron. 1977;18(2):109-13
– reference: 19696042 - Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S
– reference: 26324838 - Europace. 2015 Oct;17(10):1467-507
– reference: 23103146 - Int J Cardiol. 2013 Sep 20;168(1):515-22
– reference: 21830957 - N Engl J Med. 2011 Sep 8;365(10):883-91
– reference: 24697979 - Br J Clin Pharmacol. 2014 Oct;78(4):877-85
– reference: 21870978 - N Engl J Med. 2011 Sep 15;365(11):981-92
– reference: 23319810 - Circulation. 2013 Jan 15;127(2):169-71
– reference: 25523529 - JACC Cardiovasc Interv. 2014 Dec;7(12):1333-51
– reference: 23553523 - Circ Arrhythm Electrophysiol. 2013 Jun;6(3):460-6
– reference: 24697922 - Br J Clin Pharmacol. 2014 Oct;78(4):908-17
– reference: 28317415 - N Engl J Med. 2017 Apr 27;376(17 ):1627-1636
– reference: 27289185 - J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2215-21
– reference: 9874066 - Am J Cardiol. 1998 Dec 15;82(12):1545-7, A8
– reference: 24463370 - Circulation. 2014 Apr 15;129(15):1568-76
– reference: 20824765 - Catheter Cardiovasc Interv. 2011 Apr 1;77(5):700-6
– reference: 17659197 - J Am Coll Cardiol. 2007 Jul 24;50(4):309-15
– reference: 19572951 - J Cardiovasc Electrophysiol. 2009 Dec;20(12):1357-63
– reference: 2305397 - Stroke. 1990 Feb;21(2):230-5
– reference: 19717844 - N Engl J Med. 2009 Sep 17;361(12):1139-51
– reference: 25501801 - Circ J. 2015;79(2):339-45
– reference: 25148838 - Eur Heart J. 2014 Dec 14;35(47):3377-85
– reference: 15030415 - J Cardiovasc Electrophysiol. 2004 Mar;15(3):276-83
– reference: 24211508 - J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7
– reference: 25320240 - Blood. 2014 Dec 11;124(25):3692-8
– reference: 22700854 - Circulation. 2012 Jul 17;126(3):343-8
– reference: 9719164 - Nephrol Dial Transplant. 1998 Aug;13(8):2053-8
– reference: 10874278 - Am Heart J. 2000 Jul;140(1):150-6
– reference: 27387994 - Stroke. 2016 Aug;47(8):2075-82
– reference: 18772063 - J Am Coll Cardiol. 2008 Sep 9;52(11):924-9
– reference: 26307106 - Pol Arch Med Wewn. 2015 ;125(9):666-71
– reference: 16504638 - Am Heart J. 2006 Mar;151(3):713-9
– reference: 23210726 - Br J Clin Pharmacol. 2013 Jul;76(1):107-13
– reference: 22946890 - Br J Clin Pharmacol. 2013 Apr;75(4):1053-62
– reference: 25001152 - Am J Cardiol. 2014 Aug 15;114(4):646-53
– reference: 23121837 - CNS Neurosci Ther. 2012 Dec;18(12):988-93
– reference: 27881554 - Circulation. 2017 Jan 24;135(4):334-337
– reference: 27590218 - Lancet. 2016 Oct 22;388(10055):1995-2003
– reference: 23583249 - J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6
– reference: 23212720 - Circulation. 2013 Jan 15;127(2):224-32
– reference: 19942634 - Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):306-11
– reference: 26888149 - Circ J. 2016;80(4):860-9
– reference: 26304863 - Stroke. 2015 Sep;46(9):2555-61
– reference: 24326736 - Thromb Haemost. 2014 May 5;111(5):933-42
– reference: 22246443 - Eur Heart J. 2012 Jun;33(12):1500-10
– reference: 24946813 - Intern Med J. 2014 Jun;44(6):525-36
– reference: 22305113 - J Am Coll Cardiol. 2012 Mar 27;59(13):1168-74
– reference: 22664783 - Circ J. 2012;76(9):2104-11
– reference: 25463377 - Int J Cardiol. 2015 Feb 1;180:246-54
– reference: 11275630 - Am J Nephrol. 2001 Jan-Feb;21(1):35-9
– reference: 26162653 - Am J Kidney Dis. 2015 Oct;66(4):677-88
– reference: 15026613 - Cerebrovasc Dis. 2004;17(4):303-13
– reference: 27472258 - Int J Cardiol. 2016 Nov 1;222:47-50
– reference: 11985904 - J Am Coll Cardiol. 2002 May 1;39(9):1436-42
– reference: 27573206 - N Engl J Med. 2016 Sep 22;375(12 ):1131-41
– reference: 22402056 - Lancet Neurol. 2012 Apr;11(4):315-22
– reference: 27614026 - Heart Rhythm. 2016 Dec;13(12 ):2340-2347
– reference: 28209729 - Circulation. 2017 Mar 28;135(13):1273-1275
– reference: 24642004 - Thromb Res. 2014 May;133(5):782-9
– reference: 27890386 - J Formos Med Assoc. 2016 Nov;115(11):893-952
– reference: 26105732 - Europace. 2015 Aug;17 (8):1197-214
– reference: 17577005 - Ann Intern Med. 2007 Jun 19;146(12):857-67
– reference: 27311528 - J Am Coll Cardiol. 2016 Jun 21;67(24):2888-99
– reference: 21357827 - Circulation. 2011 Mar 15;123(10):1098-107
– reference: 21282258 - BMJ. 2011 Jan 31;342:d124
– reference: 8018000 - Arch Intern Med. 1994 Jul 11;154(13):1449-57
– reference: 23476049 - Blood. 2013 May 2;121(18):3554-62
– reference: 24810388 - Eur Heart J. 2014 Jul 21;35(28):1844-55
– reference: 26559317 - N Engl J Med. 2015 Dec 17;373(25):2413-24
– reference: 27470545 - Biomed Pharmacother. 2016 Oct;83:14-21
– reference: 22497820 - J Am Coll Cardiol. 2012 Apr 17;59(16):1413-25
– reference: 27567465 - Europace. 2016 Nov;18(11):1609-1678
– reference: 25154388 - Eur Heart J. 2014 Dec 1;35(45):3155-79
– reference: 25740669 - Circ J. 2015;79(5):1009-17
– reference: 26095867 - N Engl J Med. 2015 Aug 27;373(9):823-33
– reference: 17993293 - Lancet Neurol. 2007 Dec;6(12):1063-72
– reference: 20516376 - Circulation. 2010 Jun 15;121(23):2550-6
– reference: 27033342 - Heart Rhythm. 2016 Aug;13(8):1581-8
– reference: 8588193 - Thromb Res. 1995 Oct 15;80(2):161-8
– reference: 27687455 - J Clin Anesth. 2016 Nov;34:586-99
– reference: 24658395 - Thromb Haemost. 2014 May 5;111(5):781-2
– reference: 23610543 - Malays J Med Sci. 2012 Jul;19(3):1-7
– reference: 25368205 - Eur Heart J. 2015 Feb 1;36(5):307-14a
– reference: 26068927 - Clin Drug Investig. 2015 Jul;35(7):447-53
– reference: 27056738 - Lancet. 2016 Jun 4;387(10035):2302-11
– reference: 27296528 - J Thromb Haemost. 2016 Sep;14(9):1711-4
– reference: 9103128 - Ann Intern Med. 1997 Apr 15;126(8):615-20
– reference: 23482602 - Stroke. 2013 May;44(5):1226-31
– reference: 26088576 - Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1736-45
– reference: 26447666 - Int J Cardiol. 2016 Jan 1;202:578-85
– reference: 27435452 - Drug Saf. 2016 Sep;39(9):841-5
– reference: 25323252 - J Am Coll Cardiol. 2014 Oct 21;64(16):1658-65
– reference: 24975193 - Can J Cardiol. 2014 Aug;30(8):853-4
– reference: 23625942 - Europace. 2013 May;15(5):625-51
– reference: 24743444 - Stroke. 2014 May;45(5):1304-12
– reference: 16442406 - Am J Cardiol. 2006 Feb 1;97(3):409-11
– reference: 25406148 - Stroke. 2015 Jan;46(1):23-30
– reference: 19926009 - J Am Coll Cardiol. 2009 Nov 24;54(22):2032-9
– reference: 24607716 - Heart Rhythm. 2014 May;11(5):791-8
– reference: 22858389 - J Am Coll Cardiol. 2012 Aug 28;60(9):861-7
– reference: 24610776 - Circ Arrhythm Electrophysiol. 2014 Apr;7(2):300-6
– reference: 23237911 - Heart Rhythm. 2013 Apr;10(4):483-9
– reference: 27560276 - Lancet. 2016 Aug 20;388(10046):806-17
– reference: 26429352 - Can J Cardiol. 2015 Oct;31(10):1207-18
– reference: 23412815 - Catheter Cardiovasc Interv. 2013 Aug 1;82(2):283-9
– reference: 22934291 - J Thromb Haemost. 2012 Apr;10 (4):692-4
– reference: 24323795 - Circulation. 2014 Mar 4;129(9):961-70
– reference: 21906756 - J Thorac Cardiovasc Surg. 2011 Nov;142(5):1002-9, 1009.e1
– reference: 23782923 - J Am Heart Assoc. 2013 Jun 21;2(3):e000250
– reference: 27496855 - Circulation. 2016 Aug 23;134(8):589-98
– reference: 23850908 - J Am Coll Cardiol. 2013 Sep 24;62(13):1187-92
– reference: 23416382 - Anesthesiology. 2013 Jun;118(6):1466-74
– reference: 23062528 - J Am Coll Cardiol. 2013 Jul 9;62(2):108-18
– reference: 23325525 - Circulation. 2013 Feb 12;127(6):720-9
– reference: 25182247 - Eur Heart J. 2014 Dec 14;35(47):3346-55
– reference: 26460886 - Circ J. 2015;79(12):2560-7
– reference: 20299623 - Chest. 2010 Nov;138(5):1093-100
– reference: 25777547 - Biochemistry. 2015 Apr 7;54(13):2227-39
– reference: 20569726 - Am Heart J. 2010 Jun;159(6):1102-7
– reference: 26424865 - Eur Heart J. 2015 Dec 7;36(46):3258-64
– reference: 21515813 - J Pharmacol Exp Ther. 2011 Jul;338(1):372-80
– reference: 27067661 - Sci Rep. 2016 Apr 12;6:24376
– reference: 23305158 - Br J Clin Pharmacol. 2013 Sep;76(3):455-66
– reference: 22572202 - Lancet Neurol. 2012 Jun;11(6):503-11
– reference: 12233921 - Mayo Clin Proc. 2002 Sep;77(9):897-904
– reference: 23524209 - J Am Coll Cardiol. 2013 May 21;61(20):2079-87
– reference: 27010633 - PLoS One. 2016 Mar 24;11(3):e0150674
– reference: 26174061 - BMJ. 2015 Jul 14;351:h2391
– reference: 28302288 - J Am Coll Cardiol. 2017 Mar 21;69(11):1372-1382
– reference: 24251359 - N Engl J Med. 2013 Nov 28;369(22):2093-104
– reference: 25587708 - Kidney Int. 2015 Jun;87(6):1209-15
– reference: 21076159 - Circ Arrhythm Electrophysiol. 2011 Feb;4(1):26-32
– reference: 25377242 - Br J Clin Pharmacol. 2015 May;79(5):838-46
– reference: 19683639 - Lancet. 2009 Aug 15;374(9689):534-42
– reference: 15911722 - Arch Intern Med. 2005 May 23;165(10):1095-106
– reference: 26277496 - Heart Rhythm. 2016 Jan;13(1):46-53
SSID ssj0058411
Score 2.4625394
Snippet Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population...
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 345
SubjectTerms Age
Anticoagulants
Anticoagulation
Asian people
Atrial fibrillation
Cardiac arrhythmia
Cardiology
Diabetes
Disease prevention
Females
Guideline
Heart failure
Hypertension
Ischemia
Non-vitamin K antagonist oral anticoagulants
Patients
Risk factors
Stroke
Transient ischemic attack
Vitamin K antagonist
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fi9QwEA56ityLv39UT4ngk1Bu26RN-iSreByCp4jCvoVkmtzuebZ7267gf-8kTauLcj74miYl7Uwmk87X7yPkhaydAy2y1DoDKQddppVheVpxV1vJmLCaB7EJcXIiF4vqY_zg1kVY5RgTQ6CuW_DfyA-ZZ3rHvVryV-uL1KtG-epqlNC4Sq552Wzv52IxHbhwbw36u55yLOW5KMeqZsB3nbWedigbiDujTtu4LwX6_r_lnH9CJ39PacOedHTrf5_mNrkZs1E6H9znDrlim7vkxvtYb79HwE-dgkdcN922o62jmDDSebfSNML56DGulZ5-Wv7ol99oBIHStqFdv2m_WrqOHFHYsmqoDioh1PkfDc4HGN598uXo7ec3x2mUZUihxOiQlrLkhrPcippXOueu1JwxYypwtZEac0aJbRbPcbkuCw1M13mmucbUsKgAJHtA9pq2sY8I5TNXgJkxwwvgJpfSVtgdQy4O1rOaJWQ2GkVB5Cz30hnnagSnnSm0o_IvQ80KhXZMyMtpyHog7Lis82tv6amj59oODe3mVMWlq7jJIOM5QOAuc8wwWUpTyYxZ4TRkCTkYbaxiAOjULwMn5Pl0GZeur8foxrbbTmFyjfmq5xRMyMPBraaZ4EG2LITAm4sdh9uZ6u6VZrUM9OCFr91WeM_D4Jr_fgvq3Yc5Y7x4fPmDPCH7ftCAfjwge_1ma5-S6_C9X3WbZ2Hl_QRTqjVt
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Open Access Collection
  dbid: 24P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA6livii9drVKhF8EkYnk0wuj9tiKYK1iELfQpJJ3F3bmbIzK_jvPclc6Koogq-5zUxyzsmXOSffQeilrEJwRpDMB-sy5gzPlKVFpliovKRUeMNSsglxeirPz9XZDjoa78L0_BDTD7eoGcleRwU3tr123ly9XjWROIj01JuRE_QGIVRE0S7Y2WiOYYNNSXgj71jGCsFH12YK8vppiK3NKXH4_w54_ho_eR3Xpo3p-O5_-aQ9dGfApXjeC9I9tOPr--jW-8Hz_gC52B67GHtdt5sWNwEDdMTzdmnwENiHT0BrOvxx8b1bXOIhHBQ3NW67dfPV46uBLQpKljU2KV8IDvHKwUUfkPcQfT5---noJBsSNGSOg53IuOTMMlp4UTFlCha4YZRaq1yorDSAHiWUeTjRFYaXxlFTFcQwAyCxVM5J-gjt1k3t9xFmeSidzallpWO2kNIraA7GFzqbvKIzlI8ro93AXh6TaFzoMUxtpWHydJwMnZcaJm-GXk1drnrqjj81PozLPTWMrNupoFl_0YMSa2aJI6xwLrGYBWqp5NIqSagXwTgyQwejsOjBFLSaxhQFADIlPOPFVA1KHD0zpvbNptUAswG5RnbBGXrcy9b0JnCk5aUQMLjYkrqtV92uqZeLRBReRi-ugjHfJKn7-yzodx_mlLLyyT_3eIpux9I-NPIA7XbrjX-Gbrpv3bJdP08a-QPS9Dg2
  priority: 102
  providerName: Wiley-Blackwell
Title 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
URI https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.joa.2017.05.004
https://www.ncbi.nlm.nih.gov/pubmed/28765771
https://www.proquest.com/docview/3074762384
https://www.proquest.com/docview/1925510818
https://pubmed.ncbi.nlm.nih.gov/PMC5529598
https://doaj.org/article/4b1c142cc19643f3b3868b9813e7fac1
Volume 33
WOSCitedRecordID wos000407853500019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: DOA
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: 7X7
  dateStart: 20050801
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central Database Suite (ProQuest)
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: BENPR
  dateStart: 20050801
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: PIMPY
  dateStart: 20050801
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: WIN
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 1883-2148
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0058411
  issn: 1880-4276
  databaseCode: 24P
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1di9QwFA26ivgifq6j6xDBJ6Fs26RN8jgru-wKO5ZFcXwKSZows67tMu0I_ntv0nTYQXFffCnko0m4uWlOyOm5CL3jtXNGsSyxTpuEGlUmQpM8EdTVlhPCrKIh2ASbz_liIaobob48J2yQBx4Md0h1ZjKaGxOUoxzRhJdcC54Ry5wy4eCTMjEepoZvMOyqIfKuFxtLaM7K8T4zMLsuWy84lA2SnTFC27gjBeH-v6HNP0mTN8Fs2I1OHqNHEUbi2TD8J-iObZ6iB-fxovwZMr5nbDxVuuk2HW4dBqSHZ91K4cjDw6fg5D2-WP7qlz9wZG_itsFdv26_W3wdxZ0gZ9VgFcJ7YOf_ELga-HPP0ZeT488fTpMYTyExJSzrpOQl1ZTkltVUqJy6UlFCtBbG1ZorAHsc8iwcwHJVFsoQVeeZogowXSGM4eQF2mvaxr5EmKauMDolmhaG6pxzK6A6fCvhZZXWZILS0abSRLFxH_PiSo6ssksJ0yC9MWRaSJiGCXq_feV6UNr4V-UjP1Hbil4kO2SA68joOvI215mgg3GaZVy5nSQ-ogBgQg59vN0Ww5rzFymqse2mk4CKAWh6McAJ2h-8YjsSOIGWBWPQONvxl52h7pY0q2XQ9S78pauANg-DZ91uBfnx04wQWrz6H9Z4jR76pgdy4wHa69cb-wbdNz_7Vbeeors5reDJFiw8-RTdOzqeVxfTsPAgVZ2dV98g9fVs_hu51y4f
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFLVGh4AXvhmFAUaCF6RoSewkzgNC5WNq2VoqNKTxZGzHpt1GUpoWtD_Fb-TacQoVaDztgVfHtmzn-N7r-ORchJ6wwhglsijQRqqAKpEGuSRxkFNTaEZIpgV1ySay0YgdHubjDfSj_RfG0ipbm-gMdVEp-418h1ild_DVjL6YfQ1s1ih7u9qm0GhgsadPv8ORrX4-eA3v92kc7745eNUPfFaBQKUA7iBlKZWUxDoraC5ialJBCZEyV6aQTEDIw6BMwzEkFmkiFBFFHAkqILJJcqUYgX4voE0KYA87aHM8GI4_trYfvLnL-GtFzgIaZ2l7j-oYZUeVFTqKGqlQnxmu9YQuYcDfotw_yZq_B9HOC-5e-9_W7zq66uNt3Gs2yA20ocub6NLQMwpuIWWXCivLKS_rZY0rgyEkxr16KrAnLOI-DHuB309OF5Mv2NNccVXiejGvjjWeeRUsKJmWWLg8KNjYXylOGqLhbfThXKZ4B3XKqtR3EaahSZQMiaSJojJmTOdQHZwKNBZhQboobEHAlVdlt8lBTnhLvzvigBtuF4OHCQfcdNGzVZNZI0lyVuWXFlmrilZN3BVU88_cGydOZaQiGivl1NkMkYSlTOYsIjozQkVdtN1iinsTV_NfgOqix6vHYJzsjZModbWsORwfICK3qoldtNXAeDUSOKqnSZZB59kawNeGuv6knE6cAHpib6dz6HPHbYV_rwJ_-65HCE3unT2RR-hy_2C4z_cHo7376IrtoOF6bqPOYr7UD9BF9W0xrecP_b7H6NN5b5WfAdSS5g
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aHZp44X4pDDASvCBFbWIncR4QKoxqZaxUCKTtydiOTTtGMpoWtL_Gr-M4cQoVaDztgVff5DjH5xzHX74P4DHPrdUyDQNjlQ6YlkmQKRoFGbO54ZSmRrJabCIdj_nBQTbZgB_tvzAOVtn6xNpR56V238h71DG9Y6zmrGc9LGKyM3x-8jVwClLuprWV02hMZM-cfsfjW_VstIPv-kkUDV-9f7kbeIWBQCdo6EHCE6YYjUyas0xGzCaSUapUpm2uuMT0h2OZwSNJJJNYairzKJRMYpYTZ1pziuNegM3U6fd2YHMy2p8ctnEAI3ut_usIzwIWpUl7p1qjy45KR3oUNrShXiWujYq1eMDfMt4_gZu_J9R1RBxe-Z_X8ipc9nk4GTQb5xpsmOI6bO17pMEN0G7ZiHZY86JaVqS0BFNlMqhmknggI9nFaS_Iu-npYvqFePgrKQtSLeblZ0NOPDsWlswKImt9FGLdLxbHDQDxJnw4l0e8BZ2iLMwdIKxvY636VLFYMxVxbjJsjsEGO8t-TrvQbw1CaM_W7kRDjkULyzsSaEPCLYboxwJtqAtPV11OGqqSsxq_cFa2auhYxuuCcv5JeKclmAp1yCKta9Y2SxXlCVcZD6lJrdRhF7Zb-xLe9VXil3F14dGqGp2Wu4mShSmXlcBjBWbqjk2xC7cbk17NBI_wSZymOHi6ZuxrU12vKWbTmhg9drfWGY7Zq7fFv1dBvH47oJTFd89-kIewhftDvBmN9-7BJde_gYBuQ2cxX5r7cFF_W8yq-QPvAgh8PO-d8hP5hJuv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2017+consensus+of+the+Asia+Pacific+Heart+Rhythm+Society+on+stroke+prevention+in+atrial+fibrillation&rft.jtitle=Journal+of+arrhythmia&rft.au=Chiang%2C+Chern-En&rft.au=Okumura%2C+Ken&rft.au=Zhang%2C+Shu&rft.au=Chao%2C+Tze-Fan&rft.date=2017-08-01&rft.issn=1880-4276&rft.volume=33&rft.issue=4&rft.spage=345&rft_id=info:doi/10.1016%2Fj.joa.2017.05.004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1880-4276&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1880-4276&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1880-4276&client=summon